Podcasts about Made in China

Roughly 5,000 new electric vehicles are due to land this week from China. This is just the first part of a shipment expected from the Chinese car manufacturing behemoth, BYD. The company is due to ship another 25,000 EVs here this year. Australians are embracing electric vehicles more than ever before, thanks to skyrocketing fuel prices. But it also comes with unanswered questions and potential complications. Today, North Asia correspondent Lisa Visentin discusses China's dizzying technological advances in EVs, and whether Australians buying these cars risk being spied on.Background reading ‘Made in China’ EVs are taking over the streets, but just how safe is your data? Subscribe to The Age & SMH: https://subscribe.smh.com.au/See omnystudio.com/listener for privacy information.

Curso gratuito de IA con John Hernández: https://thebigschool.com/sp/curso-ia-agentes-a-us/ *Publi.¿Está China realmente superando a Occidente o es solo una ilusión? En este episodio, Claudio Feijóo nos revela cómo el "Made in China" ha muerto para dar paso al "Invented in China". Exploramos desde robots que cuidan ancianos hasta la obsesión por la longevidad y el control social. Una charla imprescindible para entender quién dominará el futuro.En este podcast hablamos de:El fin de la copia: El liderazgo en coches eléctricos y chips.¿Es Europa el lugar más peligroso para la narrativa china?El sacrificio generacional y la competitividad extrema desde los 7 años.Geopolítica: La relación con Rusia, EE. UU. y el control de las tierras raras.00:00 - Introducción: ¿Quién ganará la carrera tecnológica? 03:25 - La lista: Sectores donde China ya adelantó a Occidente 06:10 - De "Made in China" a "Invented in China" 10:12 - El plan maestro: Sacrificio social por liderazgo tecnológico 15:54 - Geopolítica: China frente al conflicto EE. UU. - Irán 18:38 - El secreto de las Tierras Raras: La carta ganadora de China 23:18 - Longevidad: El día que China superó a EE. UU. en esperanza de vida 26:01 - Robótica: La solución tecnológica al problema demográfico 33:17 - ¿Debemos temer o copiar la industria del coche eléctrico chino? 40:32 - IA China: ¿Más barata y eficiente que Open AI? 52:48 - Competitividad extrema: Preparando la selectividad desde los 7 años 01:10:48 - El mito del control: Conveniencia vs. Seguridad 01:25:32 - ¿Invertir en China o en EE. UU.? La visión de un economista 01:40:45 - Reflexión final: Cómo prepararse para el mundo que viene#China #Tecnología #Geopolítica #InteligenciaArtificial #Robótica #Futuro #PodcastEspañol #Economía #UriSabatEL LIBRO de La Fórmula del éxito. Aqui lo puedes conseguir

Cette semaine : RIP Spellcaster Chronicles, Subnautica 2 (Early Access), Steel Artery: Train City Builder, R-Type Dimension III, Farever, Battlestar Galactica: Scattered Hopes, Patch Dune 1.4, REPATCH Arc Raiders, gros patch pour Civilization VII, The Virtual OS Museum, Vivaldi 8.0, Infomaniak vérouille son indépendance, Ana Roxanne - Poem 1, Fuck You Bambu Lab, Mionix relance l'Avior et la Naos, Lisuan LX 7G100 : CG made in China, et AMD sort enfin le FSR 4.x sur ses vieilles cartes... Lisez plutôt Torréfaction #372 : Subnautica 2, Farever, patches pour Dune, Arc Raiders et Civilization VII, Vivaldi 8.0, et une CG made in China avec sa vraie mise en page sur Geekzone. Pensez à vos rétines.

For years, the United States told itself a reassuring story: China could manufacture and copy, but it couldn't innovate. That story is no longer credible. From DeepSeek's compute-efficient AI model to BYD's dominance of the global EV market, China is producing both volume and quality across sectors that matter. The question is no longer whether China can compete — it's whether the United States is playing its own hand well.In this episode of TechSurge, host Michael Marks speaks with Vivek Chilukuri, Senior Fellow at CNAS, where he focuses on U.S.–China technology competition, AI policy, and digital geopolitics. Vivek's path from counter-terrorism work at the State Department to tech policy in the Senate gives him an unusually grounded perspective on how government actually functions — and where it keeps failing itself.Vivek and Michael work through the full competitive landscape: the wake-up moments that shifted Washington's focus from manufacturing to technology dominance, why the dual-use nature of advanced technology has pulled the national security community into conversations once left to industry, and what Made in China 2025 actually achieved — and where it fell short.The conversation goes deep on America's policy toolkit: what the CHIPS Act accomplished and why it wasn't enough, how export controls on advanced semiconductors are working and what they're missing, and why Washington is far too weighted toward restriction at the expense of the "run faster" side of the equation. Vivek is also candid about what DeepSeek really tells us — not just about Chinese innovation, but about the gap between building a model and deploying AI at scale.They also explore the global dimension: China's "easy button" approach to technology exports, what the U.S. AI exports program is trying to do in response, the rise of "AI sovereignty" movements from Brussels to Delhi, and why the talent and immigration decisions of the past year amount to a serious self-inflicted wound.The United States still holds the best hand in the world for this competition. The question Vivek keeps returning to is whether we're playing it well — and right now, his honest answer is no.Sign up for our newsletter at techsurgepodcast.com for updates on upcoming TechSurge Live Summits and future Season 2 episodes.Episode Links:Connect with Vivek: https://www.linkedin.com/in/vivekchilukuri/Learn more about CNAS: https://www.cnas.orgTimestamps:[02:11] Wake-Up Calls: Chips & 5G[04:17] Atoms vs Bits in AI[07:27] China's Innovation Surge[10:57] Systems Capital vs Planning[14:14] Made in China 2025 Scorecard[17:23] US Tools: Chips & Controls[24:12] DeepSeek & Compute Scarcity[26:47] Energy Constraints & Scaling[29:01] AI Exports & the Easy Button[32:43] Allies & AI Sovereignty[36:13] Talent Flows & Immigration[39:04] Beyond AI: The Biotech Frontier[43:30] Founder Advice: Global South[45:20] Wrap-Up & Key Takeaways

Michael Wolff and Daily Beast executive editor Hugh Dougherty unpack Trump's bruising return from China, where the man who built his political identity around confronting Beijing now finds himself accused of capitulation, spinning shaky victories while China emerges stronger than ever. Wolff gets inside Trump's mindset as mounting crises close in at once: a worsening Iran conflict with no clear exit, rising inflation and gas prices, ICE raids fueling backlash inside and outside MAGA, explosive questions about Trump family business dealings, and a White House culture driven by grift, loyalty tests, and surreal characters like Natalie Harp shadowing the president with a portable printer full of praise. From Trump Mobile phones reportedly made in China to Kash Patel scandals and billion-dollar settlement controversies, the episode maps out an administration trapped between performance and collapse while Trump searches for a way to declare victory in situations even his closest allies can't explain away. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Most "American 250" items made in China. Trump leaves China. The Dirty Soda fad. Tonya J. Powers as Fed Chair Jerome Powell's term ends - but he plans to stick around as a fed governor.See omnystudio.com/listener for privacy information.

Ngày 14/05/2026, tổng thống Mỹ Donald Trump bắt đầu chuyến thăm Bắc Kinh. Sau những màn đón tiếp long trọng, nguyên thủ Mỹ cùng đồng cấp Trung Quốc Tập Cận Bình bước vào những vòng đàm phán, được dự báo là căng thẳng, về nhiều chủ đề. Tuy nhiên, theo nhận định từ giới quan sát, hồ sơ thương mại chắc chắn là ưu tiên thảo luận hàng đầu giữa hai nguyên thủ. Liệu rằng đôi bên có hóa giải được những căng thẳng, hay lại tiếp tục leo thang đối đầu ? Điều đầu tiên được hầu hết giới chuyên gia chia sẻ là, khác với cuộc gặp thượng đỉnh năm 2017, ông Donald Trump đến Bắc Kinh lần này trong một vị thế yếu. Cuộc chiến chống Iran do Mỹ và Israel phát động rơi vào bế tắc, trong khi cuộc chiến thuế quan mà tổng thống Trump khởi xướng vào năm 2025 không đem lại kết quả như ông muốn. Hoa Kỳ không những không chặn được đà tăng trưởng xuất khẩu của Trung Quốc bất chấp các nỗ lực của chính quyền Trump, mà còn phải hứng chịu các đòn trả đũa thương mại, công nghệ nặng nề từ Bắc Kinh. Theo nhật báo kinh tế Pháp Les Echos ngày 13/05/2026, hàng Made in China xuất sang Mỹ đã giảm mạnh trong vòng hai năm, từ mức gần 109 tỷ đô la (trong quý I/2024) xuống còn trên 67 tỷ trong quý I/2026. Nếu tính riêng trong vòng 12 tháng qua, với mức thuế từ 25-30%, nhập khẩu hàng hóa Trung Quốc vào Mỹ đã giảm 38%, một con số to lớn. Tuy nhiên, những con số này làm lu mờ một hiện tượng khác. Khi nhìn kỹ các dòng chảy thương mại, người ta sẽ thấy rằng, trong năm 2025, tỷ trọng hàng nhập khẩu từ Đài Loan vào Mỹ tăng vọt đến 94%, từ Việt Nam là 50%. Trên báo kinh tế Les Echos, Maxime Darmet, chuyên gia kinh tế tại Allianz Trade, nhận định « điều đó có nghĩa là ngành xuất khẩu Trung Quốc đang sử dụng các kênh gián tiếp. Các nhà công nghiệp Trung Quốc xuất khẩu những bán thành phẩm của họ sang các nước thứ ba, đặc biệt là Đông Nam Á, những nước này sử dụng chúng trong các dây chuyền sản xuất của mình để rồi sau đó bán thành phẩm sang Hoa Kỳ. » Hiện tượng này phản ảnh rõ năng lực thích ứng với tốc độ kỷ lục của ngành xuất khẩu Trung Quốc. Bất chấp những rào cản thuế quan, hàng hóa của Trung Quốc vẫn đến được tay người tiêu dùng Mỹ. Các số liệu thống kê của Trung Quốc thể hiện rõ nét xu hướng này : Xuất khẩu của Trung Quốc sang Đông Nam Á tăng vọt, gần như tỷ lệ thuận với mức tăng xuất khẩu của Đài Loan hay Việt Nam sang Hoa Kỳ. Cán cân thương mại vẫn nghiêng về phía Trung Quốc khi mà mức thuế nhập khẩu áp đặt cho hàng hóa của Đài Loan chỉ ở mức 3% và Việt Nam là 12% vào cuối năm 2025, trước khi có phán quyết của Tòa án Tối cao Mỹ cấm các mức thuế quan « đối ứng » do tổng thống Trump ban hành. Hệ quả là trong quý I/2026, Hoa Kỳ ghi nhận mức thâm hụt thương mại là 251 tỷ đô la, so với 274 tỷ cùng kỳ vào năm 2024. Ba mục tiêu của Donald Trump Làm thế nào điều chỉnh cán cân thương mại Mỹ - Trung vào lúc lạm phát tại Mỹ tăng cao, uy tín của ông ngày càng suy giảm khi chỉ còn vài tháng nữa là diễn ra cuộc bầu cử giữa kỳ tại Mỹ ? Trong toàn cảnh này, tổng thống Mỹ Donald Trump đến Trung Quốc với ba mục tiêu chính, theo đánh giá từ nhà phân tích về chính sách kinh tế, Agatha Kratz, thuộc nhóm tư vấn độc lập Rhodium Group, trong chương trình Affaires Etrangères, đài phát thanh France Culture, ngày 09/05/2026. Đầu tiên hết, Donald Trump muốn chuyển hướng công luận về cuộc chiến ở Iran và mang về Mỹ một số thành công như các hứa hẹn mua thêm hàng hóa Mỹ như dầu khí, nông sản, máy bay Boeing, hay những tin tốt lành cho chip bán dẫn… từ Trung Quốc. Khía cạnh thứ hai có một vị trí quan trọng : Hoa Kỳ muốn bảo đảm nguồn cung ứng đất hiếm liên tục từ Trung Quốc. Trên đài France Culture, chuyên gia kinh tế giải thích : « Rõ ràng Bắc Kinh đang nắm giữ quyền kiểm soát chặt chẽ sản xuất cũng như chế biến đất hiếm và sản xuất nam châm vĩnh cửu, những thứ cực kỳ quan trọng trong tất cả các ngành công nghiệp như công nghiệp ô tô, công nghiệp điện tử, và đặc biệt quan trọng là công nghiệp quân sự, trong bối cảnh Hoa Kỳ đã sử dụng hết một phần lớn kho vũ khí của mình và cần phải xây dựng lại, nên cần các nguyên tố đất hiếm. Do đó, nếu họ muốn chế tạo tên lửa và phục hồi năng lực quân sự và nếu muốn tiếp tục cuộc chiến ở Iran, họ cần Bắc Kinh tiếp tục cung cấp các loại đất hiếm đó. Điều này vô cùng quan trọng, và tôi nghĩ nó sẽ là một phần của cuộc thảo luận. » Vẫn theo bà Agatha Kratz, điểm thứ ba có liên quan đến cuộc chiến thuế quan của Mỹ và hiện đang vấp phải hai trở ngại : « Đầu tiên là phán quyết của Tòa án Tối cao liên quan đến thuế quan IEEPA (Đạo luật Quyền lực Kinh tế Khẩn cấp Quốc tế), phán quyết hồi tháng 2/2026 tuyên bố các loại thuế quan "đối ứng" này là bất hợp pháp. Sau đó, Tòa án Thương mại Quốc tế Mỹ (Court of International Trade - CIT) hôm 07/05, lại tuyên bố các thuế quan mới 10% theo Điều 122, được áp dụng lại sau phán quyết của Tòa án Tối cao, là bất hợp pháp. Vì vậy, hiện tại thuế quan của Hoa Kỳ đối với Trung Quốc chỉ ở mức trung bình 11%. Mức thuế này cực kỳ hạn chế nếu so sánh với mức thuế 15% đối với Liên Hiệp Châu Âu theo thỏa thuận song phương, mức thuế 18% đối với Ấn Độ, mức thuế 19% đối với Indonesia, v.v. Trung Quốc rõ ràng đang ở một vị thế cực kỳ thuận lợi, và điều đó khiến Hoa Kỳ cảm thấy rất khó chịu bởi vì, mục tiêu sau cùng của họ là giảm thiểu rủi ro trong quan hệ kinh tế với Trung Quốc, cố gắng đưa một số chuỗi giá trị trở lại Hoa Kỳ nếu có thể, hoặc ít nhất là đến các quốc gia thân thiện hơn. Và trong bối cảnh này, nếu thuế quan đối với Trung Quốc quá thấp, điều đó là không thể. Tôi nghĩ rằng đã có những công tác chuẩn bị và đàm phán sơ bộ cho việc tăng thuế quan đối với Trung Quốc, điều mà Bắc Kinh rõ ràng đã cố gắng chống lại bằng mọi cách. Đặc biệt là với Jamieson Lee Greer, người đang dẫn đầu tất cả các cuộc đàm phán thương mại, Hoa Kỳ đang cố gắng đàm phán và thúc đẩy việc tăng thuế quan hàng hóa Trung Quốc với Bắc Kinh. Tôi không chắc Mỹ sẽ thành công hay không, nhưng dù sao đi nữa, đó cũng là một trong những mục tiêu. » Bốn đòi hỏi của Tập Cận Bình Theo báo Pháp Les Echos, thặng dư thương mại Trung Quốc trong năm 2025 đạt mức kỷ lục 1.200 tỷ đô la, tức chiếm 1% GDP của toàn cầu. Theo kinh tế gia Maxime Darmet, hiện tượng này cho thấy « Trung Quốc vẫn đang dư thừa hàng hóa do tiêu thụ chưa đủ, còn Mỹ vẫn thâm hụt do tiêu thụ quá mức. Vì vậy, thuế quan không tác động đến những mất cân bằng lớn trên toàn cầu. Chúng chỉ làm chuyển hướng dòng chảy thương mại. » Nhưng cuộc chiến tranh chống Iran do Mỹ và Israel tiến hành đang bắt đầu có những tác động đối với nền kinh tế Trung Quốc. Vốn đã trì trệ một phần do cuộc chiến thuế quan, căng thẳng xung quanh eo biển Hormuz khiến giá năng lượng tăng cao, gây khó khăn cho xuất khẩu của nền kinh tế thứ hai thế giới. Hơn nữa, việc Quốc Hội Mỹ siết chặt các luật lệ kiểm soát xuất khẩu linh kiện bán dẫn gây cản trở cho nhiều lĩnh vực công nghệ chủ chốt của Trung Quốc. Đối với chuyên gia Agatha Kratz, chủ tịch Trung Quốc Tập Cận Bình có bốn điều muốn đàm phán trong thượng đỉnh lần này : « Đầu tiên hết là ổn định tình hình Iran. Trong ngắn hạn, tình hình kinh tế Trung Quốc khá tích cực, bởi vì Bắc Kinh có nhiều nguồn lực để kiểm soát lạm phát do giá năng lượng cao. Bởi vì nước này ít phụ thuộc vào dầu mỏ hơn so với nhiều nước châu Á, thậm chí so với cả nhiều nước châu Âu. Vì vậy trong ngắn hạn, tình hình là khá dễ quản lý. Nhưng trong dài hạn, điều này là đáng lo, bởi vì tình trạng đó có nguy cơ đẩy châu Âu và Đông Nam Á rơi vào suy thoái. Đây là hai thị trường xuất khẩu quan trọng nhất, chiếm đến 50% kim ngạch xuất khẩu của Trung Quốc, mà xuất khẩu chiếm đến 50% tăng trưởng kinh tế. Để dễ hình dung, việc ổn định tình hình ở Iran là vô cùng cần thiết. Thứ hai là vấn đề thuế quan như tôi đã trình bày ở trên : Trung Quốc làm mọi cách để duy trì ở mức thuế 11% hay gần với 11% như hiện tại. Thứ ba là kiểm soát công nghệ. Trên thực tế, các chu kỳ leo thang căng thẳng khác nhau trong năm 2025 đã được kích hoạt bởi những biện pháp của Mỹ đặc biệt nhắm vào xuất khẩu linh kiện bán dẫn và nhất là các loại vật liệu và thiết bị dùng để sản xuất chất bán dẫn, và Trung Quốc thì áp đặt các hạn chế xuất khẩu đáng kể đối với đất hiếm vào ngày 09/10/2025 để trả đũa các biện pháp của Mỹ. Vì vậy, tôi nghĩ Bắc Kinh chắc chắn sẽ cố gắng bóp chết ngay từ "trong trứng nước"  mọi ý định của Quốc Hội Mỹ nhằm áp đặt các biện pháp xuất khẩu và đây sẽ là một trong số các thông điệp mạnh mẽ nhất. Và Trung Quốc cũng cố gắng vận động sao cho cả Quốc Hội lẫn chính quyền cũng như bộ Thương Mại, cơ quan thực thi kiểm soát xuất khẩu, sẽ không tăng cường kiểm soát đối với chất bán dẫn, vật liệu và thiết bị sản xuất linh kiện bán dẫn ». Nhiều bình luận trước ngày họp thượng đỉnh Mỹ-Trung cho rằng cả hai bên dường như sẵn sàng có những nhượng bộ. Tuy nhiên, chuyên gia Lizzi Lee, thuộc trung tâm tư vấn Asia Society Policy Institute, trụ sở tại Hoa Kỳ, trả lời phỏng vấn AFP, lưu ý : « Ngay cả khi cuộc họp thượng đỉnh này diễn ra tốt đẹp, điều đó sẽ không làm thay đổi quỹ đạo của Trung Quốc cũng như quyết tâm của nước này đưa nền kinh tế ít phụ thuộc hơn vào Hoa Kỳ ».

As Apple prepares for a leadership shakeup and President Trump heads into high-stakes talks with Chinese President Xi Jinping, journalist Patrick McGee joins the show to explain how Apple's international expansion enabled China's technological rise. In this episode, McGee breaks down how Apple helped transform China into a global tech powerhouse—and a fierce competitor on the world stage. Get the facts first with Morning Wire.- - -Ep. 2779- - -Wake up with new Morning Wire merch: https://bit.ly/4lIubt3- - -Today's Sponsors:Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.Pocket Hose - Text MORNING to 64000 for your 2 free gifts with the purchase of any Pocket Hose Ballistic hose. By Texting 64000, you agree to receive recurring automated marketing messages from Pocket Hose. Message frequency varies and data rates may apply. Text STOP at any time to opt out. Text HELP for additional Information. No purchase required. Terms apply, available at https://PocketHose.com/terms- - -Privacy Policy: https://www.dailywire.com/privacymorning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

It's time for our annual summer reading recommendation round-up! From a book that traces the Cold War history of our “Made in China” goods, to a witchy novel about an old woman in the woods, we've got suggestions for every kind of summer. We even threw in a few podcast recs! You'll hear from Megan Doney on reading translated fiction and Austin Jersild on international history. Later in the show: Michael Carhart on understanding pre-history and Matt Brent shares a speculative Japanese novel.

Au programme de l'émission du 6 mai : avec Marie-Sabine Roger, autrice ; et avec Pauline Simon, responsable culturellePour commencer l'émission, petit coup de projecteur sur l'article Sophie la girafe, un mensonge made in China, paru ce dimanche sur Mediapart, car chacun.e d'entre nous, ou presque, a tenu ce jouet dans les mains un jour ou l'autre.LIVRES - interview Du TAC au TAC de Marie-Sabine Roger - c'est à 11 min✅Marie-Sabine Roger, autrice, a publié de très nombreux livres, romans ou albums, pour les enfants et pour les adultes. Parmi ses récents albums, L'affaire des 3 petits cochons (ingrats), illustré par Marjolaine Leray et publié au Seuil jeunesse en janvier, revisite avec beaucoup d'humour le célèbre conte traditionnel.Ici le loup, le cœur sur la main, altruiste en diable, ne souhaite rien tant que rendre service aux trois petits cochons pour les aider à construire une maison solide. Mais peine perdue, les petits cochons n'ont que faire des conseils de ce loup à qui ils n'ont rien demandé et qu'ils trouvent un peu trop collant ; ils préfèrent paresser le groin dans le foin.  À vouloir aider les autres malgré eux et imposer sa propre idée du bonheur, cela risque de mal finir pour lui.Tout est drôle et piquant dans cet album. L'histoire, bien sûr, avec cette inversion des rôles poussée jusqu'à l'absurde, la façon de la raconter et de la faire rimer en alexandrins mêlant différents niveaux de langue, jeux de mots ou mots inventés ; les clins d'œil discrets ou moins discrets à d'autres contes... Les illustrations très drôles de Marjolaine Leray participent au rythme enlevé de l'histoire. Voilà un album qu'on a plaisir à lire et relire aux enfants. 

Le Journal en français facile du mardi 5 mai 2026, 18 h 00 à Paris. Retrouvez votre épisode avec la transcription synchronisée et des exercices pédagogiques pour progresser en français : http://rfi.my/Cfsu.A

Rosemary reports back on her visit to multiple Chinese renewable energy companies, Vineyard Wind activates a $69.50/MWh PPA with Massachusetts utilities, and Bronze Age jewelry halts a German wind project. Sign up now for Uptime Tech News, our weekly newsletter on all things wind technology. This episode is sponsored by Weather Guard Lightning Tech. Learn more about Weather Guard’s StrikeTape Wind Turbine LPS retrofit. Follow the show on YouTube, Linkedin and visit Weather Guard on the web. And subscribe to Rosemary’s “Engineering with Rosie” YouTube channel here. Have a question we can answer on the show? Email us! [00:00:00] The Uptime Wind Energy Podcast brought to you by Strike Tape protecting thousands of wind turbines from lightning damage worldwide. Visit strike tape.com and now your hosts. Allen Hall 2025: Welcome to the Uptime Wind Energy Podcast. I’m your host, Allen Hall. I’m here with Yolanda Padron in Austin, Texas, who is back from the massive wedding event. Everybody’s super happy about that, and Rosemary Barnes had her own adventures. She just got back from China and Rosemary. You visited a a lot of different places inside of China. Saw some cool factories. What all happened?  Rosemary Barnes: Yeah, it was really cool. I went over for an influencer event. So if you are maybe, you know, in the middle of your career, not, not particularly attractive or anything you might have thought influencer was ruled out for you as a career. No one, no one needs engineering influencers in their [00:01:00] forties. It’s incorrect. It turns out that’s, that’s where, that’s where I, I found myself. It was pretty cool. I, I did get the red carpet rolled out for me. Many gifts. I had to buy a second bag to bring home the gifts, and when I say I had to buy a second bag, I had to mention. Oh, I have so many gifts, I’m gonna need another bag. And then there was a new bag presented to me about half an hour later. But, so yeah, what did I do? I got to, um, as I was over there for a Sun Grow event. Huge, huge event. They, um, it’s for, it’s for their staff a lot, but it’s also, they also bring over partners. They also bring over international experts to talk about topics that are relevant to them. Yeah. They gave everybody factory tours in, um, yeah, in, in shifts. Um, I got to see a module assembly factory, so where they take cells, which are like, I don’t know, the size of a small cereal box, um, and assemble them into a whole module. Then the warehouse, warehouse was [00:02:00] gigantic. It, um, was, yeah, 1.8 gigawatt hours worth of cells that couldn’t hold in that one building. They’re totally obsessed with fire safety there in everything related to batterie, like in the design of the product, but also in, in the warehouse. And they do, yeah, fire drills all the, all the time. Some of them quite big and impressive. Um, I saw inverter manufacturing facility that was really cool. Heaps of robots. Sw incredibly fast. Saw a test facility.  Allen Hall 2025: So was most of the manufacturing, robotics, or humans?  Rosemary Barnes: Yeah. So at the factory it was like anything that needed to be done really fast or with really good quality was done by robots. So they had, um, you know, pick and place machines putting in. Um, you know, components in the circuit board, like just insane, insane rate. I’m sure it’s quite, quite normal, but, um, just very fast. Everything lined up in a row. Most of their quality control is done by robots. Um, so it does well it’s done by ai, I should say. [00:03:00] Taking photos of, of things and then, um, AI’s interpreting that. Repairs, I think were done by humans. There were humans doing, um, like custom components as well. Like not every product is exactly the same. So the custom stuff was done by humans.  Allen H: So that’s the Sun Grove facility, right? You, but you went to a couple of different places within China?  Rosemary Barnes: Yeah, I went to another, a factory, a solar panel, a factory, um, from Longie. That was really cool too. I got to see a bit more probably of the, um, interesting, interesting stuff there, like, uh, a bit more. Um, yeah, I don’t, I dunno, processes that aren’t, aren’t so obvious. Not just assembly, but um, you know, like printing on, um, bus bars and, you know, all of the different connections and yeah, it was a bit, a bit more to it in what I saw. Um, so that was, but it, it’s the same, you know, as humans are only involved when it’s a little bit out of the. Norm or, um, where they’re doing repairs, actual actually re [00:04:00]repairing. You know, the robots or the AI is identifying which components don’t meet the standard and then they’ll go somewhere where a human will come and, um, fix them.  Allen H: Being the engineer there. Did you notice where the robots are made? Was everything made in China that was inside the factory or were they bringing in outside? Technology.  Rosemary Barnes: I didn’t think to look for that, but I would assume that it was Chinese made, also  Allen H: all built in country  Rosemary Barnes: 20 years ago that wouldn’t have been the case, but I think that China has had a long, a long time to, to learn that. Again, it’s not like, it’s not, it’s not rocket science. These are, these are pick and place machines, you know, like I remember working on a project very early in my career, so. Literally 20 years ago, um, I was working with pick and place machines. It’s the same, it’s the same thing. Um, some of them are bigger ’cause they’re, you know, hauling whole, um, battery packs around. It’s just the, um, the way that it’s set up, but then also the scale that they can achieve. You just, you can’t make things that cheap if you don’t have the [00:05:00] scale to utilize everything. A hundred percent. Like I said, wind turbine towers is a really good example. ’cause anyone, any steel fabricating  Allen H: shop  Rosemary Barnes: could make a wind turbine tower. Right? They, they could, they could do that. You know, the Chinese, um, wind turbine tower factories have the exact right machine. They don’t have a welder that they also use for welding bits of bridges or whatever. Uh, they have the one that does the exact kind of world that they need, um, for the tower. They, you know, they do that precisely. Robotically, uh, exactly the same. And, you know, a, a tower section comes on, they weld it, it moves off to the next thing, and then a new one comes on. They’re not trying to move things around to then do another weld in the same machine. You know, like they’re, um, but the exact right. Super expensive machine for the job costs a whole bunch to set up a factory. And then you need to be making multiple towers every single day out of that factory to be able to recoup on your cost. And so that is [00:06:00] the. The, um, bar that is just incredibly hard slash impossible for, um, other countries to clear. Allen H: Can I ask you about that? Because I was watching a YouTube video about Tesla early on Tesla, where they wanted to bring in a lot of robotics to make vehicles and that they felt like that was the wrong thing to do. In fact, they, they, they kinda locked robots in and realized that this is not the right way to do it. We need to change the whole process. It was a big deal to kind of pull those. Specialized piece of equipment, robots out and to put something else in its place in that they learned, you know, the first time, instead of deciding on a process, putting it in place and then trying to turn it on, see if it works, was to sort of gradually do it. But don’t bolt anything down. Don’t lock it in place such that it doesn’t feel like it’s permanent. So you engineer can think about removing it if it’s not working. But it sounds like this is sort of the opposite approach of. A highly specialized [00:07:00] machine set in place permanently to produce. Infinite amounts of this particular product, does that then restrict future changes and what they can make or, I, I, how do they see that? Did, did you talk about that? Because I think that’s one of an interesting approaches.  Rosemary Barnes: I didn’t actually get as much chances I would’ve liked to speak to engineers. Um, I was talking mostly to salespeople and installers. Um, so they know a lot, but I couldn’t, um, like in the factory tours, I was asking questions. Um. That kind of question and, and they could answer all, all that. Um, but outside of that, and I couldn’t record in the factory obviously. Um, but I did, I did take notes, but what I would say is that they would have a separate facility where they would be working out the details of new products and new manufacturing processes and testing them out thoroughly before they went and, you know, um, installed everything correctly. But what I do hear is that, you know, especially with solar power. Maybe to [00:08:00] batteries to a lesser extent. You, you know, you like, you have these kind of waves of technology. Um, so you know, like everyone’s making whatever certain type of solar cell and then five years later, um, there’s a new more efficient configuration and everybody’s making that. And I know that there are a lot of factories that kind of get scrapped. Um, and the way that China’s set up their, like, you know, their economy around all this sort of thing is set up is that it’s not that, like every company doesn’t succeed. Right. They SGO was a big exception because they’ve been going since 1997, I think it was. It was started by a professor quid his job and hired a room across the, across the road from his old university and, you know, built his first inverter and, um, you know, ’cause he, he could see that. Uh, the grid was gonna have to change to incorporate all of the solar power that was coming, which to be honest, in 1997, that was like pretty, pretty farsighted. That was not obvious to me when I started working in solar in mid two thousands. And it was not obvious to me that this was a winner.  Allen H: Well, has sun grow evolved then quite a bit? ’cause if you’re [00:09:00] saying that they’ve minimized the cost to produce any of their products by the use of robotics, they have been through an evolutionary process. You didn’t see any of the previous generations of. Factories. You, you were just seeing the most modern factory that that’s actually producing parts today. So is that a, is that a, is that just a cost mindset that’s going on in China? Like, we’re just gonna produce the lowest cost thing as fast as we can, or is it a market penetration approach? What are, what were, were the engineers in management saying about that?  Rosemary Barnes: I think there’s a few different aspects to that, like within China. So Sun Grow is the big company with a long track record and they’re not making the cheapest product out of China. So I think that they are still trying to make the cheapest product, but they’re not thinking about it just in the purchase price. Right. They’re thinking more in terms of the long, long term. You know, they’ve been around for 30 years and probably expect to be around for another 30 years. They don’t wanna be having [00:10:00] recalls of their products and you know, like having to, um. Installers in particular are probably working with them because they know that they won’t have to go back and do rework and the support is good and all that sort of thing. So they’re spending so much money on testing and you know, just getting everything exactly right. But I don’t think that that’s the only way that China is doing it. There’s, you know, dozens, probably hundreds of companies. Um. Doing similar stuff between Yeah, like solar panels and associated stuff like inverters and, and batteries. So many companies and all of them won’t succeed. You know, sun Girls Facility in, I was in her and it’s huge, you know, it’s like a, a medium sized country town. Just their, um, their campus there, they’re not, they’re not scrapping that and moving to a new site, you know, they’re gonna be. Rejiggering and I would expect that, you know, like everything’s set up exactly the way it needs to be, but it’s not like gigantic machines.[00:11:00] It’s not like setting up a wind turbine blade factory where it’s hard if you designed it for 40 meter blades, you can’t suddenly start making 120 meter blades. Like it’s, they will be able to be sliding machines in and out as they need to. Um, so I, I, yeah, I guess that it’s some, some flexibility. But not at the cost of making the product correctly. Allen H: Did you see wind turbines while you were in China?  Rosemary Barnes: I, the only winter I saw, I actually, I saw, because I caught the train from Shanghai, I actually caught the fast train from Shanghai to, which is about, it depends which one you get between like an hour 40 or three hours if it stops everywhere. Um, and I did see a couple of wind turbines on the way there, out the window, just randomly like a wind turbine in the middle of a, a town. Um, so that was a bit, a bit interesting. But then in the plane, on the way back, the plane from Shanghai to Hong Kong, I, at the window I saw a cooling tower of some sort. So either like a, yeah, some kind of thermal [00:12:00] power plant. And then. Around all around, well, wind turbines, so onshore wind turbines. So I don’t know. Um, yeah, I, I don’t know the story behind that, but it’s also not a particularly windy area, right? Like most of the wind in China is, um, to the west where, uh, I wasn’t  Allen H: as wind energy professionals, staying informed is crucial, and let’s face it. That’s why the Uptime podcast recommends PES Wind Magazine. PES Wind offers a diverse range of in-depth articles and expert insights that dive into the most pressing issues facing our energy future. Whether you’re an industry veteran or new to wind, PES Wind has the high quality content you need. Don’t miss out. Visit PS win.com today. So there are two stories out of the US at the minute that really paint a picture of the industry. It was just being pulled in opposite directions. The Department of Interior announced agreements to terminate two more. Offshore wind leases, uh, [00:13:00] Bluepoint wind and Golden State wind have agreed to walk away from their projects. Global Infrastructure Partners, which is part of BlackRock, will invest up to $765 million in a liquified natural gas facility instead of developing blue point wind. Ah. And Golden State Wind will recover approximately $120 million in lease fees after redirecting investment to oil and gas projects along the Gulf Coast, and both companies say they will not pursue further offshore wind development in the United States. Well, we’ll see how that plays out. Right? Meanwhile. In Massachusetts Vineyard Wind, which has been fighting with GE Renova recently has activated its long awaited power purchase agreement with three utilities. The contract set a fixed electricity price of drum roll please. [00:14:00] $69 and 50 cents per megawatt hour for the first year and a two and a half percent annual increase. Uh, state officials say the agreements will save rate payers $1.4 billion over 20 years. So $69 and 50 cents per megawatt hour is a really low PPA price for offshore wind. A lot of the New York projects that. Renegotiated we’re somewhere in the realm of 120 to $130 a megawatt hour, and there’s been a lot of discussion in Congress about the, the usefulness of offshore wind. It’s intermittent blahdi, blahdi, blah. Uh, but the, the big driver is what costs too much. In fact, it doesn’t cost too much. And because it’s consistent, particularly in the wintertime, uh, electricity prices in Massachusetts in the surrounding area are really high. ’cause of the demand and ’cause how cold it is that this offshore wind project, vineyard wind would be a huge rate saving. And [00:15:00] actually the math works out the math. Math everybody. Do you think this is, when we go back five years from now, look back at this. This vineyard wind project really makes sense for Massachusetts.  Yolanda Padron: I think it really makes sense for Massachusetts. I’m really interested to know what the asset managers are thinking on the vineyard wind side, um, and if they’re scared at all to take this on. I mean, it’s great and I’m sure they can absolutely deliver. Like generation I don’t think should be an issue. Um. I just don’t know. It’s, it sounds like they’re leaving a lot of money on the table.  Allen H: I would say so, yeah. But remember, the vineyard win was one of the early, uh, agreements made when things were, this is pre Ukraine war, pre Iran conflict on a lot of other, a lot of other things. It was pre, so I remember at the time when this was going on that. P. PA prices were higher than obviously a lot of other [00:16:00] things. Onshore solar, onshore wind, it would, offshore is always more expensive, but I don’t remember $69 popping up anywhere in any filing that I remember seeing. So even if they had said $69 five years ago, I think that would’ve still been like, wow, that’s pretty good for an offshore wind project. And now it looks fantastic for the state of Massachusetts  Yolanda Padron: because I know that there’s sometimes, and we’ve talked about this in the past, right? There are sometimes projects where, you know, you think you, you’ve got a really good price and you’re really excited about it, and then it goes into operation and then like a couple years down the road, prices increase quite a bit and it’s not the worst thing in the world. But you do just kind of think a little bit like, I wish I could. Renegotiate this or you know, just to get, to get our team a bit of a better deal or to get a bit more money in operations and everything.  Allen H: Does this play into Vineyard wind claiming $850 [00:17:00] million in dispute with GE Renova that at $69 PPA, there’s not a lot of profit at the end of this and need to get the money out of GE Renova right now, and maybe why GE Renova wants to get out of this because they realize. The conflict that is coming that they need to separate the, the themselves from this project. It’s, it’s very, as an asset manager, Yoland, as you have done this in the past, would you be concerned about the viability of the project going forward, or is all the upfront costs. Pretty much done in that operationally year to year. It’s, it’s not that big of a deal.  Yolanda Padron: As an asset manager taking this on, I’d probably have started preparation on this project a lot earlier than other of my projects like I do. I know that usually there’s, you know, we’ve talked about the different teams, right, throughout the stages of the project until it goes into operations, [00:18:00] but. And usually you don’t have a lot of time to prepare to, to make sure all of your i’s are dotted and t’s are crossed, um, by the time you take the project and operations from a commercial standpoint. But this project, I think would absolutely, like you, you would need to make sure that a lot of the, of the things that you’re, that might be issues for some of your projects like aren’t issues for this project. Just to make sure at least the first few years you can. You can avoid a lot of, a lot of turmoil that the pricing and the disputes and the technical issues are gonna cause you, because I feel like it’s just, there’s, there’s just so many things that just keep this side, just keeps on getting hit, you know? Allen H: Well, I, I guess the question is from my side, Yolanda, is obviously inflation, when this project started was pretty consistent, like one point half, 2%. It was very flat for a long time. And interest rates, if you remember when this project started, were very, very low. Almost [00:19:00] nonexistent, some interest rates. Now that’s hugely different. How does a contract get set up where a vineyard can’t raise prices? It would just seem to me like you would have to tie some of the price increase to whatever the inflation rate is for the country, maybe even locally, so that if there were a, a war in Ukraine or some conflict in the Middle East. That you, you would at least be able to, to generate some revenue out of this project because at some point it becomes untenable, right? You just can’t afford to operate it anymore. And,  Yolanda Padron: and I think, um, I, I haven’t, I obviously haven’t read the, the contracts themselves, but I know that there’s sometimes there, it’s pretty common for a PPA to have some sort of step up year by year. And it’s usually, it can be tied to, um, the CPI for. Like the, the change in CPI for the year to year. So you’re [00:20:00] absolutely like, right, like maybe, I mean, hopefully they’re, they’re not just tied to the fixed 69 bucks per megawatt hour. Um, but, but yeah, to, to your point like that, that price increase could, could really save them. Now that we’re, we’re talking the, the increase in, in inflation right now and foreseeable future,  Allen H: if you think about what electricity rates are up in the northeast. I think I was paying 30 cents a kilowatt hour, which is 300. Does that sound right? $300 a megawatt hour. Delivered at the house, something like that. Right? So  Yolanda Padron: prices in the northeast are crazy to me,  Allen H: right? They’re like double what they are in North Carolina. Yeah. Delamination and bottom line failures and blades are difficult problems to detect early. These hidden issues can cost you millions in repairs and lost energy production. C-I-C-N-D-T are specialists to detect these critical flaws [00:21:00]before they become expensive burdens. Their non-destructive test technology penetrates deep dip blade materials to find voids and cracks. Traditional inspections completely. Miss C-I-C-N-D-T Maps Every critical defect, delivers actionable reports and provides support to get your blades. Back in service, so visit cic ndt.com because catching blade problems early will save  Yolanda Padron: you millions. Allen H: Well, sometimes building a wind farm turns out more than expected construction workers at a 19 turbine wind project in lower Saxony Germany under Earth. What experts call the largest Bronze age Amber Horde ever found? The region, the very first scoop of an excavator brought up bronze and amber artifacts that stopped construction and brought archeologists back to the site. Uh, the hoard has been dated between [00:22:00] 1500 and 1300 DCE and is believed to have belonged to at least three. Status women possibly buried as a religious offering. Now as we push further and further across Germany with wind turbines and solar panels for, for that matter, uh, we’re coming across older sites, uh, older pieces of ground that haven’t been touched in a long time and we’re, we’re gonna find more and more, uh, historically significant things buried in the soil. What is the obligation? Of the constructor of this project and maybe across Europe. I, I would assume in the United States too, if we came across something that old and America’s just not that old to, to have anything of, of that kind of, um, maybe value or historically significant. What is the process here? Rosemary Barnes: I assume that they’ve gotta stop, stop work. Um, yeah, that’s my, my understanding and I don’t think, do you have [00:23:00] grand designs in America?  Allen H: I don’t know what that is. Yes.  Rosemary Barnes: So missing out by not having that chat. It’s a TV show about people who are building houses or doing, um, ambitious renovations, and it just, it follows, it follows them. You can learn a lot about project management or. The consequences if you decide that you don’t need to, project management isn’t a thing that you need to do. Um, anyway. I’m sure that in some of those ones I’ve seen they have had work stop because in their excavation they found a, um, yeah, some, some kind of relic, um, from the, from the past. So based on that very well-credentialed experience that I have, I can confidently say that they would be stopping stopping work on that site. I mean, it’s so bad, bad for the developer, I guess, but it’s cool, right? That they’re, you know, uncovering, uh, new archeology and we can learn more about, you know, people that lived thousands of years ago. Allen H: It, it does seem [00:24:00] like, obviously. Do push into places where humans have lived for thousands of years. We’re going to stumble across these things. Does that mean from a project standpoint, there’s, there’s some sort of financial consequence, like does the lower Saxony government contribute to the wind turbine fund to to pay the workers for a while? ’cause it seems like if they’re gonna do an archeological dig. That that’s gonna take months at a minimum, may, maybe not, but it usually, having watched these things go on it, it’s. It’s long.  Rosemary Barnes: But wouldn’t that be something that you’d have insurance for?  Allen H: Oh, maybe that’s it.  Rosemary Barnes: You know, it seems to me like an insurable, an insurable thing, like not so hard to, it would’ve affected plenty of other, like any project that involves excavation in Europe would come with a risk of, um, finding Yeah. An archeological find. And having work stopped, I would assume.  Allen H: Yolanda, how does that work in the United States do, is there some insurance policy towards finding [00:25:00] a. Ancient burial ground and what happens to your project?  Yolanda Padron: I don’t know. I, um, the most I’ve heard has been, it’s just talking to like the government and like the local government and making sure that you have all your permits in place and making sure, you know, you might need to, to have certain studies so you know, you might not have to get rid of the whole wind farm or remove the hole wind farm, but at least a section. Of it has to be displaced from what you originally had thought. I don’t know. I know it happens a lot in Mexico where you get a lot of changes to construction plans because you find historical artifacts or obviously not everybody does this, but like. Tales of construction workers who will like, find, they’re so jaded from finding historical artifacts that they just kind of like take and then dump them to the next plot over to not deal with it right now. Not that it’s anything ethical, uh, or done by everybody, [00:26:00] uh, but it’s, but, but it’s a common occurrence, a relatively common occurrence.  Allen H: You would think it where a lot of wind turbines are in the United States, which is mostly Texas and kind of that. Midwest, uh, wind corridor that they would’ve stumbled across something somewhere. But I did just a quick search. I really hadn’t found anything that there wasn’t like a Native American burial ground or something of that sort, which they previously knew. For the most part. It’s, so, it’s rare that, that you find something significant besides, well, maybe used some woolly mammoths tusks or something of that sort. Uh, in the Midwest, it’s, it’s, so, it’s an odd thing, but is there a. A finder’s fee? Like do does the wind company get to take some of the proceeds of, of this? Trove of jewelry.  Rosemary Barnes: I, I would be highly surprised.  Allen H: Well, how does that work then? Rosemary?  Rosemary Barnes: I’d be highly surprised if that’s the case in Europe. I bet it would happen like that in America. Allen H: Sounds like pirate bounty in a sense.  Rosemary Barnes: In, in Australia it wouldn’t be like that because [00:27:00]you, when you own land, you don’t actually. You, you own the right to do things from surface level and above, basically. I don’t know how excavation works. So you don’t generally have a a right to anything you find like that? I mean, you shouldn’t either. It’s not, it’s not yours. It’s a, it belongs to the, I don’t know, the people that, that were buried. When you then to the, the land, like, I guess. The government in some way. I mean, in Australia it’s, um, like we don’t have so many archeological fines that you would find from digging. I mean, it’s not that there’s none, but there’s not so many like that. But it is pretty common that, you know, there are special trees, um, you know, some old trees that predate, uh, white people arriving in Australia. And, um, you know, that have been used for, you know, like it might have a, a shield that’s been, um. Carved out of it. Or, uh, hunting. Hunting things, ceremonial things, baskets, canoes, canoe like things, stuff like that. They call ’em a scar [00:28:00] tree ’cause they would cut it out of a living, living tree. And you know, so when you see a tree with those scars and that’s got, um, cultural significance. There’s also, you know, just trees that were, um. That that was significant for cultural reasons and so you wouldn’t be able to cut down those trees if you were building any, doing any kind of development in Australia and a wind farm would be no different. I know that they are, there are guidelines for, if you do come across any kind of thing like that or you find any anything of cultural significance, then you have to report it and hopefully you don’t just move it onto the neighboring property. Allen H: I know one of the things about watching, um. Some crazy Canadian shows is that. Uh, you have to have a Treasure Hunter’s license in Canada. So if you’re involved in that process, like you can’t dig, you can’t shovel things, only certain people can shovel. ’cause if they were to find something of value, you. You’ll get taxed on it. So there’s just a lot of rules [00:29:00] about it. Even in Canada,  Rosemary Barnes: if I was an indigenous Australian and you know, some Europe person of European descent came and found some artifacts, uh, aboriginal. Artifacts. I would be pissed if they just took it and sold it. Like that’s just clearly inappropriate right. To, to do that. So you, I don’t think it should be a free for all. If you find artifacts of cultural significance and you just, it’s, you find its keepers that, that doesn’t sound right to me at all.  Allen H: Can we talk about King Charles II’s visit to the United States for a brief moment? Uh, he is a really good ambassador, just like, uh, the queen was forever. He’s, he does take it very seriously and the way that he interacted with the US delegation was remarkable at times in, in terms of knowing how to deal with somebody that there’s a war going on right now. So there’s a lot [00:30:00] happening in the United States that, uh, not only could it be. Uh, respecting both sides of the UK and the United States’ position in a, in a number of different areas, but at the same time being humorous, trying to build bridges. Uh, king Charles, uh, had the scotch whiskey tariffs removed just by negotiating with President Trump, and sometimes that’s what it takes. It’s a little bit of, uh. Being a good ambassador.  Allen H: Yeah. The very polished you would expect that. Right? But this is the first visit of. The king to the United States, I believe. ’cause he, he’s been obviously as a prince many, many, many times to the United States. [00:31:00]But this time as, as a, the representative of the country, the former representative or head of the country, which was unique. I think he did a really good job. And I wish he, they would’ve talked about offshore wind. Maybe he could’ve calmed down the administration on offshore wind.  Rosemary Barnes: I bet that’s one of the, the goals. I mean, that’s an industry that’s important to. So  Allen H: I wonder if that happened actually. ’cause that’s not gonna be reported in, in the news, but how the UK is going on its own way in terms of electrification and I guarantee offshore wind had to come up it. Although I have been not seen any article about it, I, I find it hard to believe that King Charles being the environmentalist that he is, and a proponent of offshore wind for a long time. Didn’t bring it up and try to mend some fences.  Rosemary Barnes: Maybe he’s playing the long game though. I mean, Trump is pretty, he’s transactional, but he also, you know, he has people that he really likes and you know, will act in their interests. So maybe it’s enough to just be [00:32:00] really liked by Trump, and then that’s the smartest way you can go about it. Allen H: Did you see the gift that King Charles presented to, uh, the US this past week? It was a be from, uh, world War II submarine, which was the British, I dunno what the British called their submarines, but it was, the name of it was Trump. So they had the bell from. The submarine when it had been commissioned and they, they gave that to the United States, or give to the president. It goes to the United States. The president doesn’t get to keep those things, but it was such a smart, it’s a great president. It’s such a smart gift, and somebody had to think about it and the king had to deliver it in a way that got rid of all the noise between the United States and the uk. Brought it back to, Hey, we have a lot in common [00:33:00] here. We shouldn’t be bickering as much as we are. And I thought that was a really smart, tactful, sensible way to try to men some fences. That was really good. That wraps up another episode of the Uptime Wind Energy Podcast. If today’s discussion sparked any questions or ideas, we’d love to hear from you. Reach out to us on LinkedIn. Don’t forget to subscribe, so you never miss this episode. And if you found value in today’s conversation, please leave us a review. It really helps other wind energy professionals discover the show. For Rosie and Yolanda, I’m Allen Hall and we with. See you’re here next week on the Uptime Wind Energy Podcast.

Thank you to all our listeners and supporters for getting F&FC to 200 episodes! We are proud of the work done and are looking forward to much more content! Stay tuned!China's grand strategy to reshape supply chains, ideological dominance, and the larger world order can be traced to strategies like Made in China 2025. How much of a wake-up call is this for the U.S.? Emily de la Bruyère, Senior Fellow at the Foundations for Defense of Democracies (FDD) and co-founder of Horizon Advisory, joins the podcast to share some of China's boldest strategies and their threats to U.S. national security and prosperity. Could a bigger wake-up call motivate a more ambitious national security vision and strategy from the U.S.?Learn more from Emily's work at FDD! https://www.fdd.org/team/emily-de-la-bruyere/Support the showVisit georgewashingtoninstitute.org to sign up for our e-mail list! The site is the one-stop shop of all things Friends & Fellow Citizens and George Washington Institute!JOIN as a Patreon supporter and receive a FREE Friends & Fellow Citizens mug at the $25 membership level!IMPORTANT NOTE/DISCLAIMER: All views expressed by the host are presented in his personal capacity and do not officially represent the views of any affiliated organizations. All views presented by guests are solely those of the interviewees themselves and may or may not represent the views of their affiliated organizations, the host, Friends & Fellow Citizens, and/or The George Washington Institute.

A four-star admiral just stood on the floor of Congress and told senators that the US military is actively researching Bitcoin for national defense. Not as an investment. Not as a hedge. As a weapon. In this episode, Dennis Porter of Satoshi Action Fund breaks down what happened in that room, why the Pentagon is running a Bitcoin node, how proof of work can protect military communications from Chinese cyberattacks, and why 97% of mining hardware being made in China is a massive national security problem. He also reveals the behind-the-scenes fight to get a strategic Bitcoin reserve attached to the NDAA, why the crypto market structure bill is likely dead because of one clause nobody is talking about, and why states are quietly banning Bitcoin ATMs while the federal government stockpiles it. This is the most important Bitcoin policy conversation happening right now, and almost nobody is paying attention. Learn more about your ad choices. Visit megaphone.fm/adchoices

E V's Made In China

‘Made in China' is not the insult it once was. It now means world-leading, culture-defining tech innovation.Is it being used for the betterment of mankind? Can Western civilisation cope with a world where China leads, without defaulting to xenophobia?These questions arise amid a backdrop of digital work clones and an afterlife avatar of lost loved ones - stay ahead of the curve with Jag, Jen and Felina on Disconnected this week…This episode of Disconnected covers:China's evolving tech leadership and Western identityAI, work, and the erosion of dignityGrief, intimacy and digital humansThe gap between AI hype and economic realityJag Sharma: https://www.linkedin.com/in/jagsharmahttps://www.instagram.com/jagsharma/Jen Campbell:https://www.linkedin.com/in/jennifer-m-campbell/Jason Kapadia:https://www.linkedin.com/in/jasonkapadia/https://www.instagram.com/jasonkapadia/Felina Tan:https://www.linkedin.com/in/felinagabrielletan/

Don't forget to send us your questions or subject for future episodes.Subscribe/Follow, give us a rating and give us a follow on Instagram for all the latest Podcast news - https://www.instagram.com/drivetorque...Cheers and see you at the next one

What if the H-1B visa experience — the lottery, the waiting, the uncertainty about whether to buy a sofa or commit to a relationship — could be experienced in a game? Journalist and game developer Alison Yang did exactly that. Yang talks to Immigration Nerds host, Lauren Clarke, about her upcoming simulation game h1b.life, which drops players into the daily reality of navigating the U.S. immigration system, managing money, legal costs, social support, and mental health, all while outcomes can still spin on a slot machine you don't control.Resource Links:https://h1b.life/https://www.wired.com/story/made-in-china-a-new-game-turns-the-h-1b-visa-system-into-a-surreal-simulation/HOST: LAUREN CLARKE NEWS NERD: ROB TAYLOR PRODUCER: ADAM BELMAR

The European Union has unlocked a $100 billion loan for Kyiv - money that's been stuck for months. Hungary had been holding it up, arguing it wasn't receiving Russian oil through a key pipeline that runs across Ukraine. That line was damaged after a Russian strike earlier this year, but Kyiv says repairs are now complete and oil is flowing again.Plus, we get a rare insight into what it's like trying to run a shop or even buy bread in Iran these days.And we look at the rise of quality Chinese retail brands, challenging the perception that “Made in China” means cheap and of poor quality.

Some serious stuff lands better with humor, so help yuck up some doom and gloom with the Garage Hour gearheads.  We've got the potential peril of cars made in China (everything from unactuated robot cars and vampire technology to dangerously chintzy products and blatant trademark infringement) and the real-life lessons you and we can learn from the rinse-and-repeat episodes of Tiger Woods' DUIs (let the celeb make the mistake for you).  From there, there's some thought development on a schism developing in the used car market (new and old - divergent, but why?), and a reminder that some tech is easy to fix because it's easy to fix (geeks can do stuff!). Also in there:  loads of Led Zeppelin (Physical Graffiti, of course), and some adventures in foam with beer from the sale shelf (why not enjoy some beer tourism?).

Some serious stuff lands better with humor, so help yuck up some doom and gloom with the Garage Hour gearheads.  We've got the potential peril of cars made in China (everything from unactuated robot cars and vampire technology to dangerously chintzy products and blatant trademark infringement) and the real-life lessons you and we can learn from the rinse-and-repeat episodes of Tiger Woods' DUIs (let the celeb make the mistake for you).  From there, there's some thought development on a schism developing in the used car market (new and old - divergent, but why?), and a reminder that some tech is easy to fix because it's easy to fix (geeks can do stuff!). Also in there:  loads of Led Zeppelin (Physical Graffiti, of course), and some adventures in foam with beer from the sale shelf (why not enjoy some beer tourism?).

張炤和 張禹宣 林廷輝

This week: Rage dropping 0-Day Claude Mythos, things are different now From UART to root, on a device made in China, where's the FCC? More CUPS vulnerabilities Russians are hacking routers, FCC ban doesn't stop them Mongoose vulnerabilities, and FCC still does nothing Renting virtual phones Iran's cyber attacks SHA-256 almost broken? Catching Axios New Rowhammer, dubbed GPUBreach, gives you root Windows 11 has sudo! (And SSH...) And Inside a Kubernetes Scanning Fleet Visit https://www.securityweekly.com/psw for all the latest episodes! Show Notes: https://securityweekly.com/psw-921

This week: Rage dropping 0-Day Claude Mythos, things are different now From UART to root, on a device made in China, where's the FCC? More CUPS vulnerabilities Russians are hacking routers, FCC ban doesn't stop them Mongoose vulnerabilities, and FCC still does nothing Renting virtual phones Iran's cyber attacks SHA-256 almost broken? Catching Axios New Rowhammer, dubbed GPUBreach, gives you root Windows 11 has sudo! (And SSH...) And Inside a Kubernetes Scanning Fleet Show Notes: https://securityweekly.com/psw-921

This week: Rage dropping 0-Day Claude Mythos, things are different now From UART to root, on a device made in China, where's the FCC? More CUPS vulnerabilities Russians are hacking routers, FCC ban doesn't stop them Mongoose vulnerabilities, and FCC still does nothing Renting virtual phones Iran's cyber attacks SHA-256 almost broken? Catching Axios New Rowhammer, dubbed GPUBreach, gives you root Windows 11 has sudo! (And SSH...) And Inside a Kubernetes Scanning Fleet Visit https://www.securityweekly.com/psw for all the latest episodes! Show Notes: https://securityweekly.com/psw-921

This week: Rage dropping 0-Day Claude Mythos, things are different now From UART to root, on a device made in China, where's the FCC? More CUPS vulnerabilities Russians are hacking routers, FCC ban doesn't stop them Mongoose vulnerabilities, and FCC still does nothing Renting virtual phones Iran's cyber attacks SHA-256 almost broken? Catching Axios New Rowhammer, dubbed GPUBreach, gives you root Windows 11 has sudo! (And SSH...) And Inside a Kubernetes Scanning Fleet Show Notes: https://securityweekly.com/psw-921

Re-Air Date: 04-07-26 Original Air Date: 1-15-2025 Elon Musk is leading the way for his class of tech broligarchs anxious to take over the MAGA movement and shape it to their own ends of deregulation, tax cuts, and lucrative government contracts. The disappointment that is inevitable for the MAGA populists is coming even faster than expected. Be part of the show! Leave a voice message, message us on Signal at the handle bestoftheleft.01, or email Jay@BestOfTheLeft.com Full Show Notes Check out our new show, SOLVED! on YouTube! BestOfTheLeft.com/Support (Members Get Bonus Shows + No Ads!) Join our Discord community! KEY POINTS KP 1: The long con of America's ultra-wealthy elites - The ReidOut - Air Date 1-2-25 KP 2: Crack-Up Capitalism- How Billionaire Elon Musk's Extremism Is Shaping Trump Admin & Global Politics - Democracy Now! - Air Date 1-6-24 KP 3: GOP Already At Each Other's Throats While Musk Gloats - The Muckrake Political Podcast - Air Date 12-24-24 KP 4: MAGA civil war explodes between Elon & Trump faithful - No Lie with Brian Tyler Cohen - Air Date 12-29-24 KP 5: Elon & Vivek's H1-B Crash Out - Bad Faith - Air Date 1-2-25 KP 6: Our Moment is Approaching - The Muckrake Political Podcast - Air Date 12-31-24 KP 7: Weekly Roundup Jimmy Carter vs Elon Musk - Straight White American Jesus - Air Date 1-3-25 KP 8: The Oligarch Class - Left Anchor - Air Date 1-3-25 (55:36) NOTE FROM THE EDITOR On the rehashing of the anti-democratic argument for extreme wealth for the benefit of humanity DEEPER DIVES (1:07:48) SECTION A: OLIGARCHS (1:35:31) SECTION B: THE MAGA FRACTURE (1:51:12) SECTION C: GLOBAL INFLUENCE (2:21:52) SECTION D: ORGANIZING SHOW IMAGE Description: Composite image of a close-up of a MAGA hat with a tag attached that says "Made in China". The hat has cracks and the head of Elon Musk pokes out through a tear in the fabric. Trump's eyes are visible below the hat brim. Credit: Composite design by A. Hoffman | Images from Pixabay | License: Pixabay

Former Acting Director of the Defense Intelligence Agency David Shedd joins hosts Ray Powell and Jim Carouso to discuss his bestselling book “The Great Heist: China's Epic Campaign to Steal America's Secrets.” Shedd reveals how China has executed the largest illicit wealth transfer in history - an estimated $600 billion per year in stolen Intellectual Property - and why it matters to everyone from Main Street workers to Indo-Pacific allies.In Ep. 138, Shedd breaks down China's “capture, cage, and kill” strategy that lures Western companies with market access, traps them with restrictive laws, then undercuts them with cheaper copies of their own technology. He traces the campaign from Deng Xiaoping's 1984 vision through Made in China 2025 and explains how two false Western assumptions - that China would play by WTO rules and eventually democratize - left the door wide open.The conversation covers the Tesla-to-BYD pipeline, the sale of advanced Nvidia chips, China's hypersonic breakthroughs built on stolen stealth technology, Salt Typhoon and Volt Typhoon cyber intrusions embedded in critical infrastructure, and what allies like Japan, South Korea, Australia, and the Philippines are doing - or not doing - to respond. Shedd also delivers a direct simulated intelligence briefing to U.S. President Donald Trump ahead of his planned Beijing summit, warning that China's Ministry of State Security now fields over 300,000 operatives with a dedicated bureau targeting the United States.This podcast is essential listening for policymakers, business leaders, academics, and anyone concerned about the intersection of economic security, technology competition, and the future of the Indo-Pacific.

Jeff welcomes back Ron Hardman and Kilroys Workshop to Crosswalk Colorado Springs. There is a national movement toward training in the trades. Kilroy’s Workshop is leading the way! And you want to hear about them making the sabers for USAFA graduates - “made in COS” rather than “made in China”See omnystudio.com/listener for privacy information.

Watch the full podcast! https://chinauncensored.tv/programs/podcast-329 Like a lot of things made in China, it's easier to buy them when you don't know the backstory. That's the case for Chinese wigs, which come in all various shades and colors that are not what most Chinese hair would look like. We spoke with Ethan Gutmann, author of The Xinjiang Procedure, about where these wigs are coming from. Order your copy of The Xinjiang Procedure now: https://www.amazon.com/Xinjiang-Procedure-Ethan-Gutmann/dp/1968919201 Ethan Gutmann is an award winning author, journalist, and all around interesting guy.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

David Shedd served as acting director of the Defense Intelligence Agency; Andrew Badger is a former DIA case officer now teaching state-sponsored espionage at Oxford. Together they've written The Great Heist: China's Epic Campaign to Steal America's Secrets. Matt talks with them about how the Ministry of State Security evolved from a backwater service into what they argue is the world's most powerful intelligence agency; how Beijing replaced Cold War recruitment tradecraft with guanxi-based social obligation and what the authors call "crowd-sourced espionage"; how Made in China 2025 functioned as a national collection priority list driving theft across defense, tech, and critical infrastructure; and why Volt and Salt Typhoon represent not an espionage story but pre-positioning for war—with kill switches already embedded in America's power grid and telecommunications backbone.Subscribe and share to stay ahead in the world of intelligence, global issues, and current affairs.Order The Great Heist: https://www.harpercollins.com/products/the-great-heist-david-r-sheddandrew-badgerConnect with David and Andrew on LinkedIn:https://www.linkedin.com/in/david-shedd-00a32bb5https://www.linkedin.com/in/andrewbadger1Please share this episode using these linksAudio: https://pod.fo/e/3a9846YouTube: https://youtu.be/3jCFWGhI7_wSupport Secrets and SpiesBecome a “Friend of the Podcast” on Patreon for £3/$4: https://www.patreon.com/SecretsAndSpiesBuy merchandise from our shop: https://www.redbubble.com/shop/ap/60934996Buy us a coffee: https://buymeacoffee.com/secretsandspiesSubscribe to our YouTube page: https://www.youtube.com/channel/UCDVB23lrHr3KFeXq4VU36dgFor more information about the podcast, check out our website: https://secretsandspiespodcast.comConnect with us on social media Bluesky: https://bsky.app/profile/secretsandspies.bsky.socialInstagram: https://instagram.com/secretsandspiesFacebook: https://facebook.com/secretsandspiesSpoutible: https://spoutible.com/SecretsAndSpiesFollow Chris and Matt on Bluesky:https://bsky.app/profile/chriscarrfilm.bsky.socialhttps://bsky.app/profile/mattfulton.netSecrets and Spies is produced by Films & Podcasts LTD: https://filmsandpodcasts.co.uk/Music by Andrew R. BirdPhoto by ShutterstockSecrets and Spies sits at the intersection of intelligence, covert action, real-world espionage, and broader geopolitics in a way that is digestible but serious. Hosted by filmmaker Chris Carr and writer Matt Fulton, each episode examines the very topics that real intelligence officers and analysts consider on a daily basis through the lens of global events and geopolitics, featuring expert insights from former spies, authors, and journalists.

Today I want to talk about something that looks like it belongs in an auto industry newsletter, but it's actually a leading indicator for the broader economy, and it matters for real estate investors.Walk onto an auto dealer lot today and you'll see a lot more sheet metal sitting still than you're used to seeing. The lots look full, and in many cases, they are. But the more important metric is not “how many cars you see,” it's how long they're sitting there.Cox Automotive reported that in January 2026 the U.S. market began February with inventory around 2.77 million units, and the key line was this, days' supply jumped to 98, driven by a notably slower sales pace. When days' supply rises, the story is simple, the vehicle is not moving, the consumer is hesitating. And that jump happened fast. Cox noted days' supply around 76 in the prior period, then up to 98 as sales slowed. CarEdge tracks market day supply by vehicle, essentially how long it would take to sell existing listings at the current sales pace. In late winter 2026, some models are showing truly abnormal numbers, deep into the multiple hundreds of days. The attached notes you provided list examples like the Dodge Charger around 406 days, the Jeep Grand Wagoneer around 463 days, and the Volkswagen ID.4 around 480 days of supply, which is beyond “slow,” that's a demand breakdown at the price point. Even some Korean cars are showing huge inventory. The Hyundai Sonata has 201 days of inventory on dealer lots. The Hyundai Santa Crus has 222 days on dealer lots. The Buick Envision which incidentally is made in China has 267 days of inventory on dealer lots. The are more than a dozen models with over 200 days of inventory on dealer lots. ------------**Real Estate Espresso Podcast:** Spotify: [The Real Estate Espresso Podcast](https://open.spotify.com/show/3GvtwRmTq4r3es8cbw8jW0?si=c75ea506a6694ef1)   iTunes: [The Real Estate Espresso Podcast](https://podcasts.apple.com/ca/podcast/the-real-estate-espresso-podcast/id1340482613)   Website: [www.victorjm.com](http://www.victorjm.com)   LinkedIn: [Victor Menasce](http://www.linkedin.com/in/vmenasce)   YouTube: [The Real Estate Espresso Podcast](http://www.youtube.com/@victorjmenasce6734)   Facebook: [www.facebook.com/realestateespresso](http://www.facebook.com/realestateespresso)   Email: [podcast@victorjm.com](mailto:podcast@victorjm.com)  **Y Street Capital:** Website: [www.ystreetcapital.com](http://www.ystreetcapital.com)   Facebook: [www.facebook.com/YStreetCapital](https://www.facebook.com/YStreetCapital)   Instagram: [@ystreetcapital](http://www.instagram.com/ystreetcapital)  

We are saying goodbye to Foreign Film February (or #FFF for the insiders) with a bang (or is it a clang?) with 1972's SEVEN BLOWS OF THE DRAGON and 1972's THE WATER MARGIN.  Is this episode the podcast equivalent of a double feature?  Not really.  You see, some of us watched SEVEN BLOWS OF THE DRAGON and one of us watched THE WATER MARGIN. And while SEVEN BLOWS OF THE DRAGON and THE WATER MARGIN are essentially the same thing except one of them is 35 minutes shorter... and makes even less sense.  Joining us is returning guest Dirk Marshall from the VH US podcast (https://www.vh-us.com/), who we normally bring in for his expertise in Canadian films, and figured he would do the same for a movie made in China.  We do our best to piece together a considerably complex plot for a movie that should be more fighting and less talking, which is exactly what Roger Corman wanted.  In addition to unraveling the plot, Erica delivers blows to the team for incorrect statements and general bossiness.  Dirk correctly points out that the nicknames applied to characters in SEVEN BLOWS OF THE DRAGON do little to trigger memory retention for the 100 characters in this movie. He also identifies good nicknames during the episode. Ryan tries his best to get the tracking right for his audio clips.  Erica talks about a totally unrelated movie.  Guess this episode is a double feature after all. For more about the New World Pictures Podcast, including previous episodes, t-shirts, mugs, sweatshirts, other merch and more, head here: https://newworldpicturespodcast.com/For all the shows in Someone's Favorite Productions Podcast Network, head here:  https://www.someonesfavoriteproductions.com/ 

What if the reason you’re not healing isn’t that you need another diagnosis? 0:08 It’s that your cells aren’t receiving the right signals. Because the body doesn’t run on diagnosis, it runs on 0:16 communication. And peptides are one of the most powerful, most misunderstood 0:21 tools we have for cellular signaling, immune balance, tissue repair, gut 0:27 lining support, metabolic control, brain signaling, sleep cycles, and even sexual 0:35 wellness. Today, I’m going to do what most people won’t. Define peptides in 0:41 plain English for you. break them into categories by what they’re best at and 0:47 tell you which ones are FDA approved on the list and which ones are commonly 0:53 used off label or investigational with the evidence that actually says these 1:00 work. This is going to be a powerful episode and if you’ve ever felt like you’re hearing hype without clarity, 1:07 this one’s for you. So, as usual, grab your cup of coffee or tea and settle in 1:13 as we talk about peptides that can fit into your healing journey. We’re going 1:19 to have a short word from our sponsor. You know, we got to do that. That’s how we stay on the air here. So, we will be 1:26 right back after this. Did you know sweating can literally heal your cells? 1:32I nfrared saunas don’t just relax you. They detox your body, balance hormones, 1:37 and boost mitochondrial energy. I’m obsessed with my health tech sauna. And 1:42 right now, you can save $500 with my code at healthtechalth.com/drmuthqen25. 1:54 All right, here we go, guys. I am excited to dive into peptides with you. 2:00 So understanding peptides is foundational, right? And I’ve been 2:06 studying peptides now for about nine years. Um, and I find that they are 2:13 incredible. Um, so I want to break down for you what peptides actually are, what 2:19 they do, and some of the top peptides that are available today, and how they 2:25 can be utilized. Because I think it’s really important. And I think it’s it’s there’s a lot of confusion out there about what these things actually are and 2:32 are they safe? Are they not? When do we use them? What’s the science behind them? So, we’re going to dive in and 2:38 we’re going to talk about all things peptides. So, let’s get ready here. Here we go. So, peptides are short chains of 2:45 amino acids and they typically range anywhere from 2 to 50 amino acids and 2:51 they’re linked by peptide bonds. So think of them as the superglue that holds the amino acids together. They sit 2:58 between the amino acids and they are full proteins in terms of their size and 3:04 their complex structure. And what makes peptides particularly interesting in 3:10 medicine is their role as signaling molecules. They’re essentially the 3:15 body’s text messages carrying specific instructions to cells and tissues. And 3:21 unlike our proteins which often serve as structural roles or act as enzymes, 3:28 peptides typically function as hormones, neurotransmitters and growth factors and 3:33 they bind to specific receptors on the cell’s surfaces or within the cells and 3:39 they trigger this effect. It’s like a cascade effect of a biochemical reaction 3:45 that ultimately changes the cellular behavior. So basically, it’s changing 3:50 the way the body’s cell structure acts. And this is why peptides can be so 3:56 incredibly powerful and therapeutic when you introduce the right peptide signal. 4:02 Now, you could theoretically redirect cellular processes toward healing, 4:07 towards metabolism, immune balance, tissue repair. Any of those things can 4:14 be manipulated to do a certain thing once we add the peptide. The challenge 4:19 in peptide medicine though lies in distinguishing between those peptides that have been rigorously studied, 4:26 proven safe and effective and approved by regulatory bodies like the FDA versus 4:31 those that exist in what we call the gray zone of a promising clinical data. 4:36 But they really lack human validation so far. And this distinction is critical because the presence of a plausible 4:43 mechanism does not guarantee safety or efficacy in living humans. So, this is 4:50 really important and we’re going to dive in and look at some of the research on all of these different peptides that are 4:56 available and I’m excited to say there’s some amazing peptides being studied right now that unfortunately are not 5:01 available. But I can’t wait to see them hit the market for us because it is going to be a gamecher as far as health 5:09 and longevity. So there is a quality control issue and there is a hidden 5:14 variable in peptide medicine with this and it’s one of the most underappreciated aspects of peptide 5:21 therapy particularly for non-FDA approved peptides. It’s quality control. 5:26 When we discuss pharmaceutical medicines, we take for granted that the pill contains what the label says. Not 5:32 always true depending on where it comes from. You guys, if you’ve heard my episodes before talk about how many of our medications are made in China and 5:41 have been contaminated with other things, you will realize that that is not always true. So, just because it has 5:48 the FDA stamp of approval on the medication, it still does not necessarily mean it’s safe and we still 5:54 need to do our homework on it. So, sorry for digressing on you guys, but you know, when we get a medication, we we 6:00 think that what the amount says is what is there, doesn’t have contaminants, it’s manufactured with good 6:06 manufacturing practices. You’ll see that listed as GMP on the bottle, and it’s been stored properly, it’s been 6:12 maintained stable, and with research peptides and compounded formulations, 6:17 none of this can be assumed. So, I will share a story with you. There was a gentleman that was purchasing these 6:24 peptides online from a research facility and um did not know that they were 6:30 coming from China and he was ordering a particular growth hormone peptide and 6:35 after a little while he had he had done fine for the few first few bottles. After a little while he started having 6:42 some complications. He started getting really irritable and angry and ragy and 6:47 he didn’t quite know what was going on. And so he decided to go get some testing done. He had some blood testing done and 6:53 his testosterone level was over 5,000. So for those of you who know what testosterone level should be for a guy, 7:00 they really shouldn’t be any higher than about 1,00200 would be absolute max that we’d want to see. Now he was taking 7:06 testosterone but not to that degree. And prior to adding this peptide, his 7:12 testosterone was very stable. What they ended up finding out was the peptide that he was getting, whoever was 7:18 manufacturing it added testosterone to the peptide. They felt like if if it had growth hormone, that was great, but if 7:25 it had growth hormone and tes testosterone, all the better. And he didn’t know that. And this is the 7:31 problem that we can have with peptides if you don’t source them properly. if you’re not working with somebody that 7:37 knows how to source them and can prove that they are what they say they are. Um, I’m sure there’s a whole bunch of 7:42 studies out there too of people getting these peptides and paying hundreds of thousands of dollars for them over their 7:48 lifetime and finding out they were nothing more than just sterile water. So, you really do need to be careful 7:53 with your quality control. Now, this kind of leads us right into the next topic that we’re going to talk about and that’s the manufacturing question, 8:00 right? The FDA approved peptides are manufactured in facilities subject to 8:05 the FDA inspection rules following our GMP regulations and these facilities 8:11 must validate their manufacturing process, demonstrate consistency batch to batch, test for purity and potency. 8:18 They need to test for bacterial endotoxins and sterility and they need to maintain detailed records. So, when a 8:25 pharmaceutical company submits a drug application, the FDA inspects the manufacturing facility as part of the 8:32 approval process. If you’re getting peptides from a different country, none of that is happening. And there are some 8:38 ways for us to determine if that is what you’re getting. Typically, the rule of thumb is if your peptides are coming 8:44 with a different colored top, every one of them has a different colored top. Those are typically being sourced out of 8:49 China. I wouldn’t say that’s 100% but that’s kind of the rule of thumb that people follow. So compoundingies these 8:56 are thearmacies that make our bio identical hormones. They can make medications in any dose or strength or 9:02 route. There are thousands of them in every not that not in every state but 9:08 there are thousands of them around the country right now. So these compoundingies are registered as 503A 9:15 facilities. They do traditional compounding for individual prescriptions, right? Like they can make 9:20 thyroid, they can make LDN, they can make estrogen. You can also have a 503b 9:27 facility, which is an outsourcing facility. And these companies produce larger batches of products. They’re they 9:34 have some oversight, but they’re less stringent than for FDA approved 9:40 manufacturers. And state boards of pharmacy regulate a 503A pharmacy. And 9:45 the FDA can inspect the 503b facility, but doesn’t preapprove any of their 9:52 compounding products. So, they can inspect it, but they don’t approve them. So, research chemicals and these 9:58 suppliers operate essentially with no oversight. They explicitly market products for research use only, not for 10:06 human consumption to avoid FDA regulation. If they put that on their 10:12 product, they don’t have to comply to what the FDA is saying. And there is no required manufacturing strategies or 10:19 standards, no required testing, no required sterility assurance, and no enforcement mechanisms if products are 10:26 mislabeled or contaminated. So basically, they don’t have the liability, but that doesn’t mean that 10:31 all of them are badies or bad suppliers. It just means they don’t have to comply 10:37 to the FDA rules. Now, there are many of these companies that I’ve seen and I’ve talked to that do do a lot of this. They 10:44 do test their product for sterility. They do test their product to make sure it is what it says it is. They don’t 10:51 have to, but they do. So, if you’re going to decide to use a company that 10:56 has research only, not for human consumption, at least ask for their 11:02 proof of testing so that you know that the product you’re getting is what it says it is and that it’s clean. Because 11:08 this is where we run into the problem is in purity. So in purity peptide 11:13 synthesis can produce not just the targeted peptide but also related 11:19 peptides with deletions, substitutions, truncations or truncations of amino 11:25 acids. Sorry. And this high performance liquid we call it uh chromatography can 11:30 separate these related impurities and quality and quantify the actual target 11:35 of the peptide content. So a certificate of analysis is what you want to ask these companies for. This shows the HPLC 11:44 the testing mechanism with greater than 95% or ideally 98% purity which 11:51 indicates a higher quality product. So this certificate of analysis can be fabricated may not represent the 11:57 specific batch being sold. It happens. We need to know not everybody is honest. Not everybody, you know, does what they 12:03 say and it does what’s right. But at least you at least they’re giving you something and you have some security. 12:10 and then choose a company that was referred to by someone else that has done some homework as well. In in 12:16 commercial research, there’s independent testing and they research peptides and this has been really shocking 12:23 variability that they’ve seen. Some products contain 50% or less of the 12:29 claimed peptide and some contained primarily degradation of the product or manufacturing impurities and some 12:36 contained bacterial endotoxins at levels that could cause fever and systemic 12:42 inflammation if it was truly injected. And I would also worry with some of those problems, you know, depending on 12:48 what impurity or bacterial endotoxin was there. If you’re using a product to boost your immune system and your immune 12:54 system is already compromised, these bacterial endotoxins can actually make you sicker instead of what you want it 13:02 to do, which is making you better. So, sterility is always an issue with anything that is manufactured, 13:08 especially things that we’re doing as an injection. Peptides are intended for injection. They must be sterile. They 13:16 must be kept safe. And pharmaceutical manufacturers conduct this sterility testing on every batch. 13:22 Compoundingarmacies should conduct sterility testing particularly for high-risisk compounded 13:28 sterile preparations and research chemical suppliers may or may not conduct any testing. So injecting 13:35 non-sterile material can cause local infections, abscesses at the injection 13:41 site and or if the bacteria enters the bloodstream could potentially be 13:46 life-threatening and you could have sepsis. Now, excuse me. We saw this 13:52 happen in a compounding pharmacy uh gosh, it’s probably been 10 years ago 13:57 now, I think. um they unfortunately had a strep uh contamination in their 14:03 product and they weren’t testing it. It was a large compounding pharmacy out of Florida and they were making products 14:08 that were being injected into the joints and um these people got very very sick 14:14 and some of them died and um some of them got very very injured by this uh 14:21 complication that happened. So it’s not like this doesn’t happen. It does, but it doesn’t happen often. And that’s what 14:28 we have to know about. And so, when we’re talking with you guys about storage and stability, it’s really 14:34 important to make sure you maintain your peptides well. So, many peptides are unstable at room temperature. They 14:41 require refrigeration or freezing. We tell everyone to make sure you’re refrigerating your peptides. That way, 14:48 there’s no question about it. when it stays cold um it prevents or slows down 14:54 the process of uh bacteria growing in it. So some of these peptides actually 14:59 degrade very rapidly in the solution and they must be reconstituted immediately before use and reconstitution of the 15:07 peptides really has limited stability often just days to weeks not months. So 15:13 improper storage, temperature, um changes during shipping or prolonged 15:19 storage of a reconstituted product can lead to degradation into inactivity or 15:25 potentially even a harmful breakdown of the product itself. So if you have a product that’s been sitting in your 15:30 refrigerator for a month or two months or 3 months or 6 months, just throw it away. It’s not going to be any good. 15:37 you’re not going to actually get the peptide and the uh potency that you’re looking for anyway out of it and the 15:44 potential of you introducing an endotoxin, a bacterial endotoxin is quite high at that point. So you just 15:50 really don’t want to take the risk, excuse me. So what practitioners, what 15:56 should we do and what should patients do? Well, for any peptide therapy, we 16:03 want to source our verification. know where the peptide product comes from. Is 16:08 it an FDA approved product? Is it a 503b compounding? A research chemical 16:14 supplier? Is there a certificate of analysis? Request and review this COA. 16:20 And you want it to show purity greater than 95% but ideally greater than 98%. 16:27 You want that identity be identity to be confirmed by mass spectromedy. Uh 16:33 sterility testing should be done. Bacterial endotoxin testing should be done. Batch number matching of the 16:39 product that you received should be done. Proper storage. You want to know that this has been refrigerated or 16:46 frozen as directed once it’s been mixed. Look at the expiration dates for reconstituting your peptides. Track that 16:53 reconstitution date and discarded accordingly like we just talked about. Monitor for your adverse effects. Even 17:01 with the perfect quality control, monitoring for adverse effects is essential with questionable quality and 17:08 vigilance is really critical here. I know it’s frustrating for a lot of patients when they have to get several 17:15 bottles and they only last a week or two. right here, you guys. This is why 17:21 they only last a short period of time because once they’re mixed, they start 17:26 to degrade and they won’t be good and you won’t get the benefit from it. So, 17:31 it’s really important with these research peptides specifically, practitioners should recognize that all 17:38 recommending products without quality assurance violates the fundamental medical principle of first do no harm. 17:45 If a patient is determined to use research peptides despite counseling, providing guidance on quality 17:52 verification, requesting those COAs, using pharmaceutical grade sources when available, proper testing, this all 17:59 reduces harm, but doesn’t constitute necessarily that recommendation. Now, 18:06 that being said, today it’s very difficult to find peptides by the compoundingies because of what the FDA 18:13 has done. So most of the peptides that are available to us have been labeled 18:18 not for human consumption, not because they’re not good products, but because 18:25 of what the FDA did. And this is how these companies have been able to 18:31 continue to provide peptides to the medical community. And if you know you 18:36 have a good company, then you’re, you know, you’re still taking the risk, right? But at the end of the day, the 18:42 reason they’re doing that is to protect themselves from the FDA, from liability. Um, so just kind of know that there is 18:50 some talk in the community with um Bobby Kennedy that this is going to change and 18:55 they are going to bring peptides back to the compounding pharmacies. Now, we don’t know which ones they’re going to 19:01 bring back. Uh, will it be all of them? Will it just be some of them? What’s going to happen here? Um, is it going to 19:07 go to the pharmaceutical companies like our GLP1s did? We don’t know what that’s going to look like quite yet. Um, but it 19:14 is coming and that is positive news. So, let’s talk now about FDA approved 19:21 peptide medications. So, this is the metabolic revolution, right? GLP1 19:28 and our dual increeting agonists. This is an exciting time. GLP-1s are amazing. 19:35 Um, a lot of people are skeptical, a lot of people love them, a lot of people hate them. Whichever side of the fence 19:42 that you’re on, I understand. But I want to talk about the science of it today 19:48 and what it actually means for people. So, the story of GLP1 glucagon like 19:54 peptide one represents one of the most significant advances in metabolic 19:59 medicine in the past several decades. GLP-1 is an accretin hormone. It’s 20:05 gutder derived peptide that potentiates insulin secretion in response to food 20:11 intake. And the body naturally produces GLP-1 in the intestinal L cells, but it 20:17 rapidly degraded by the enzyme DPP4 giving it a halflife of only about 2 20:24 minutes. So this rapid breakdown made in therapeutically impractical until 20:31 research was developed and modified the analoges that resist the enzyme degradation. So for those people who 20:39 never feel full when they’re eating, never feel satisfied when they’re done, this is because their body is either not 20:46 producing enough GLP1 or it’s not getting the signal right. And this is a 20:51 leptin issue. This is an insulin issue. It’s a GLP-1 issue. It’s a complicated 20:56 issue. This is not anything that the person is doing wrong. It’s what is happening to their body. And so GLP1s 21:03 have really revolutionized this. So one particular GLP-1 that we have is 21:09 semiglutide. And this GLP-1 agonist is what changed everything in the world of 21:16 metabolic medicine. Semiglutide is marketed as ompic for type 2 diabetes 21:23 and it’s marketed as WGOI for chronic weight management. It is a modified 21:29 GLP-1 analog with 95 or sorry 94% amino acid sequence uh homology to human 21:37 GLP-1. So it means that it’s it’s just like our own GLP-1 that we make. This 21:42 modification includes specific amino acid substitutions and the addition of C18 21:50 a fatty acid chain which allows the peptide to bind to albumin. Now this 21:56 albumin binding dramatically extends the half-life to approximately one week 22:01 enabling one weekly dosing which is a major advantage over the earlier GLP-1 22:07 agonists that require daily or twice daily injections. The mechanism by which 22:13 semiglutide works is multiaceted. At the pancreatin level, it binds to GLP-1 22:20 receptors on the pancreatic beta cells enhancing glucose depending sorry 22:27 enhancing glucose dependent insulin secretion. This glucose dependency is 22:33 crucial. It means the peptide only stimulates insulin release when blood glucose is elevated. This dramatically 22:41 reduces the hypoglycemic risk compared to insulin or even uh sulfuras. 22:47 Simultaneously semiglutide suppresses glucagon secretion from pancreatic alpha 22:53 cells further improving glycemic control. This is really amazing because 23:00 over the years when we’ve used insulin, which is also a peptide by the way, you 23:05 had to dose it just right because if you didn’t, you would produce so much insulin that it would crash the blood 23:12 sugar and then somebody would have too low of a blood sugar. They’d be hypoglycemic and they’d have to eat more 23:18 sugar and then they’d have to modify the insulin again and the person would be going up and down, up and down, up and 23:24 down all day long. And that created a lot of problems for people and so this 23:30 helps to stabilize that so it is not such an intense change. Now in the GI 23:36 tract semiglutide delays the gastric emptying particularly pronounced during 23:41 the initial weeks of therapy. This slowing of the gastric emptying contributes to the sensation of being 23:48 full and early satiety that patients often describe. However, this effect 23:54 tends to attend to weight over time as the body adapts through the appetite 24:00 suppressing effects generally persist through central mechanisms. So, when we 24:05 talk about what is actually happening, we’re slowing that digestive process down. That’s why people aren’t so 24:11 hungry. It’s why they’re not eating so much. This is why people can develop constipation with these products because 24:17 it’s slowing the body’s digestive tract down. Now some people will call this 24:22 gastroparesis. Um gastroparesis is actually different. 24:28 It is when we lose control over what’s happening in the in the colon like the 24:34 nerves and things like that just stop working. I have never seen that with the GLP1s that we prescribe in micro doing. 24:42 um it’s been documented. It can happen, but again it a lot of it is dosing and a 24:48 lot of it is staying on top of your client and what’s happening and what’s going on and what you’re doing and making sure that they do have good 24:54 motility still. So a lot of these things can be mitigated if you have problems 24:59 with them. Now one of the most profound effects of semiglutide occur in the 25:05 central nervous system. GLP-1 receptors are widely distributed in the brain 25:10 particularly in the hypothalamus and the brain stem area where we are involved in 25:15 appetite regulation. So when when wilding and colleagues published their 25:20 landmark step one trial in the New England Journal of Medicine in 2021, 25:25 they demonstrated that participants receiving 2.4 4 milligrams of semiglutide weekly achieved an average 25:32 weight loss of 14.9% of their body weight over 68 weeks. Now, I want you 25:39 guys to really understand this. We’re talking roughly 15% body weight loss 25:45 over a year, longer than a year. 52 weeks is a year, right? This is 68 25:50 weeks. So, it took longer for them to lose. We’re not talking about giving 25:55 somebody a dose to lose 15% of their body mass in a month or two. That that 26:01 is not healthy for any of us. That is not what we’re talking about doing here. Now, they compared this to placebo and 26:08 the placebo was only 2.4%. So, that is a significant difference. 26:14 And even beyond the numbers, patients reported something very qualitatively different, a reduction in what’s now 26:21 called food noise. Everybody knows what food noise is. We’ve talked about this long before GLP1. It’s that craving. 26:28 It’s that part of your brain that just keeps thinking about I want to eat something. You know, that was actually 26:34 reduced and they didn’t expect to see that happen. Now, this refers to the constant mental preoccupation with food, 26:42 the intrusive thoughts about eating, the difficulty in feeling satisfied. Semi-glutide appears to appears to 26:49 modulate reward pathways in the misolyic system reducing hedonic eating and food 26:57 cravings. Now there are also great cardiovascular effects of semiglutide 27:02 that extend beyond weight loss. Uh the sustained six and select trials 27:07 demonstrated significant reductions in major adverse cardiovascular events uh 27:14 mace in high-risisk populations. The select trial published in 2023 showed 27:20 that semiglutide reduced cardiovascular death, non-fatal myioardial inffection 27:25 and non-fatal stroke by 20% in adults with overweight or obesity and 27:31 established cardiovascular disease but without diabetes. So this suggests that 27:37 mechanisms beyond glucose control and weight loss possibly including 27:42 anti-inflammatory effects, improvements in endothelial function and favorable 27:47 changes to lipid profiles. Now I will tell you the clients that I work with that are on GLP1, 27:53 they will tell you that their inflammation has been significantly reduced. We are also seeing really 28:00 amazing results in lipid profiles. um part of its weight loss, but there is a 28:06 component to this that is lowering the triglyceride levels because it’s related to sugar and how the body’s processing 28:11 it. And we’re seeing better profiles, less need for statins as a result of 28:17 that. If if you want to listen to my episode on statins, I have one on that. Uh they are not my favorite medication. 28:24 I think it’s overprescribed and overused um and not really affecting or 28:29 addressing the problem. So these things can really be helpful. There’s also some 28:34 uh ramblings going on with GLP-1s saying that they may be able to help with 28:40 addiction in the future because of where they’re finding it affecting the brain and how it affects the food noise and 28:47 the cravings that we have for food and the addiction for food. Could it potentially help with other addictions 28:53 down the road? We’ll have to wait and see on that one. So semiglutide’s FDA prescribing information also includes a 29:00 box uh boxed warning about thyroid sea cell tumors. So in rodent studies 29:06 semiglutide caused dose dependent and treatment duration dependent sea cell 29:12 tumors at clinically relevant exposures. So while it’s unknown whether or not 29:17 semiglutide causes uh thyroid cancer tumors in humans and the rodent thyroid biology 29:26 differs significantly from humans, the drug is contraindicated in patients with a personal or family history of 29:33 medillary thyroid carcinoma or in patients with multiple endocrine neopl neoplasia syndrome type two. it is 29:42 uh contraindicated for safety effects with that. Um I have seen endocrinologists okay GLP1s to be used 29:50 in patients who’ve had other forms of thyroid cancer just not the meillary 29:55 thyroid cancer. So there is possibility there. Now the most common side effects 30:00 are gastrointestinal. It’s nausea affects about 20 to 44% of patients 30:06 depending on the formulation with diarrhea, vomiting, constipation, abdominal pain, and also frequently 30:13 reported in clinical trials. I see this in my clinic, too, especially dose dependent. Um, and it happens early on 30:20 when you’re first starting the medication, but seems to settle out over time. The one that I would add to this 30:26 that I don’t think they have on here is an increase in acid reflux. We also see that quite often uh especially in people 30:33 who suffer with acid reflux to begin with. Now these effects are typically most 30:40 pronounced during the escalation and they like I said often improve over time 30:45 but more serious but less common adverse effects include acute pancreatitis. 30:51 The medication needs to be discontinued immediately if this is confirmed. You can see some diabetic retinopathy 30:57 complications in patients with pre-existing retinopathy and acute kidney injury. Um, this usually happens 31:05 secondarily to dehydration from the GI effects. There are some gallbladder disease um that can occur and people who 31:13 have a sensitive gallbladder will describe uh discomfort with that. I’ve 31:18 even seen some people who’ve had their gallbladder out on GLP1s at the higher doses complain of similar pain that they 31:25 used to have when their gallbladder was in. So, really important to just kind of monitor these symptoms and work closely 31:32 with somebody that understands them and can be on top of them quite quickly if this happens. Excuse me. From an 31:39 integrative medicine perspective, semiglutide really represents a powerful tool, but it’s not a standalone 31:46 solution. Remember, the medication addresses one aspect of the metabolic dysfunction, the signaling systems 31:53 controlling appetite and glucose homeostasis, but it doesn’t address the root cause that led to the metabolic 32:00 disease in the first place. Patients who rely solely on the medication without addressing the ultrarocessed food 32:07 consumption, the ccadian disruptions, the chronic stress, the sleep apnea, or 32:12 underlying hormonal imbalances often experience weight regain when the medication is discontinued. 32:20 The drug is also not a substitute for addressing the emotional and psychological drivers of eating 32:26 behavior, including the unresolved trauma that may manifest as emotional eating. I think this is really important 32:33 because we don’t address the trauma issue enough with clients and we need to 32:38 be looking at that. There is a huge trauma effect out there these days that is I don’t want to say leading to or 32:45 causing but it is definitely contributing to chronic illness and it’s not being talked about enough. So we 32:52 really need to be talking about this and addressing this trauma aspect. Now the next GLP that one that I want to talk 32:59 about is trespathide. This is a dual agonist. It takes center stage. It is my 33:05 favorite GLP one. Trisepatide is marketed as Mangjaro for type 2 diabetes 33:11 and Zepbound for chronic weight management and it represents the next 33:16 evolution in increantbased therapy. This is a dual agonist a 39 amino acid 33:23 synthetic peptide structurally based on the human glucose dependent insulin tropic peptide so GIP sequence but 33:31 modified to activate both the GIP receptors and the GLP1 receptors. So the 33:37 addition of the GI GIP agonism to the GLP1 agonism appears to create this 33:46 synergistic effect that goes beyond simply adding the two mechanisms together. So the GIP like GLP-1 is an 33:55 increant hormone secreted by what is called the K cells in response to nutrient intake. It enhances glucose 34:02 dependent insulin secretion but it also effects on atapost tissue metabolism 34:09 potentially improving the insulin sensitivity in fat cells and influencing 34:14 how the body stores and metabolizes fat. So some research suggests that GIP may 34:20 also have effects on energy expenditure though this remains an area of 34:26 investigation. So basically what we’re saying is this drug may actually help 34:32 people who are insulin resistant or insulin sensitive, not just somebody who 34:38 has problems with glucose control. So, this is super exciting because it opens 34:43 up the door for all of these people for decades that we’ve been trying to manage with insulin resistance and trying to 34:50 prevent diabetes and honestly most of the time have been unsuccessful 34:56 unless you can keep your diet at 50 grams of carbs or less a day, which is extremely difficult. Um, and take some 35:04 supplements that may or may not work and or take some metformin that may or may not help. this drug actually really 35:11opens that up and helps in that capacity. So there was a clinical trial 35:17 called the surmount clinical trial which demonstrated that trespathide produces 35:22 even more substantial weight loss than semiglutide. In the surerount one trial published by uh J tree I might have said 35:31 that wrong. I apologize if I slaughtered your name and colleagues in the New York England Journal of Medicine in 2022. 35:38 Participants receiving the highest dose of trespide, which is 15 milligrams, achieved an average weight loss of 20.9% 35:47 of their body weight over 72 weeks, compared to 3.1% with placebo. This 35:54 level of weight loss approaches what’s typically only seen in beriatric surgery. So, this is amazing because if 36:02 this medication works and we don’t have to do beriatric surgery, stomach stapling basically, um, oh my gosh, it’s 36:11 amazing. There are so many complications and risks that go with stomach stapling and the different procedures that they 36:17 do these days. People don’t absorb their nutrients properly. They have to do liquid nutrients. It’s very complicated. 36:24 It’s very challenging. Many of these people gain their weight back. Um, and 36:30 this procedure is not fun to go through. So, if we could change that and change 36:35 the lives of people who’ve really been struggling, it is amazing. And I will tell you that I have seen this work. I 36:42 have seen people lose 100 150 pounds on these medications over a year or two 36:50 period of time. It is definitely slower than beriatric surgery on some standpoints, but that is okay. You don’t 36:56 want that rapid weight loss. It’s not good for you. It’s not healthy for you. It doesn’t look well. You know, we want 37:03 to do this safely and effectively in the best way that we can possibly do that for you. Now, the adverse effect profile 37:10 is similar to semiglutide. It’s dominated by gastrointestinal effects. 37:15 Nausea, diarrhea, decreased appetite, vomiting, constipation. These were all commonly reported in the surmount 37:22 trials. And like semiglutide, tricepide carries a blackbox warning regarding the 37:27 thyroid sea cell tumors based on the rodent data and it shares the same contra indications in patients with a 37:34 family history of thyroid cancer and men too. So the mechanism behind why 37:40 tepatide often produces more substantial weight loss than GLP-1. The agonism 37:45 alone remains under investigation, but it may relate to the complimentary effects on the different aspects of 37:51 energy homeostasis or to GIP’s effects on atapost tissue and potentially on 37:58 central central nervous system pathways that GLP1 alone doesn’t fully address. 38:03 Now patients often report even more profound reductions in food noise with tricepide compared to GLP1 and uh sorry 38:12 GLP1 the agonists through this is anecdotal and hasn’t been regularly 38:17 quantified in quality studies. So I’ve done both uh personally and in my 38:22 practice. I really like trespide better than semiglutide. For me I had too many side effects with semiglutide. uh I had 38:30 less side effects with trespathide. I also plateaued on semiglutide which I 38:35 didn’t really care for. And with Tresepide, I haven’t plateaued and I’ve been able 38:42 to lose about 25 pounds in um a year and a half and I’ve been able to maintain 38:49 that. Um and I continued to use it because I do have a strong family history of cardiovascular disease. And 38:56 if this could help me so that I don’t follow my family lineage with cardiovascular disease, I am all for 39:03 trying to do that. I’ve watched too many of my family members suffer from this. I’ve lost my dad at a very young age. I 39:09 lost my grandfather at a young age to it. All of their brothers to this. And I don’t want to be that same person. So 39:16 that is why I chose to do that. And I think it’s really important for us to take a look at that and understand that. 39:24 Now, I know this has been a really long podcast and I don’t typically do podcasts this long. I have a whole host 39:31 of information on additional peptides. So, I’m going to break this up for you 39:36 guys and I’m going to do another episode and we’re going to pick up where we left off here with these peptides so that we 39:43 can actually start to dive into different peptides as well. So, check 39:48 out my next podcast show when we’re going to dive into the peptides that 39:54 talk about sexual wellness, immune function, and all the other cool things 39:59 that we can do with peptides. So until then, remember to like, share, and 40:04 subscribe. It really helps us get out to other people and share our information, 40:10 and join us for our next episode as we continue the talk about peptides. 40:15 Welcome to Let’s Talk Wellness Now, where we bring expert insights directly to you. Please note that the views and 40:21 information shared by our guests are their own and do not necessarily reflect those of Let’s Talk Wellness Now, its 40:28 management, or our partners. Each affiliate, sponsor, and partner is an 40:34 independent entity with its own perspectives. Today’s content is provided forformational and educational 40:40 purposes only and should not be considered specific advice, whether financial, medical, or legal. While we 40:48 strive to present accurate and useful information, we cannot guarantee its completeness or relevance to your unique 40:56 circumstances. We encourage you to consult with a qualified professional to address your 41:01 individual needs. Your use of information from this broadcast is entirely at your own risk. By continuing 41:08 to listen, you agree to indemnify and hold Let’s Talk Wellness Now and its 41:14 associates harmless from any claims or damages arising from the use of this 41:20 content. We may update this disclaimer at any time and changes will take effect 41:26 immediately upon posting or broadcast. Thank you for tuning in. We hope you 41:31 find this episode both insightful and thought-provoking. Listener discretion 41:36 is advised.The post Episode 256 – How Peptides Work, Benefits, and FDA-Approved vs Off-Label Use Explained first appeared on Let's Talk Wellness Now.

Sen and Erica speak with Liqin Gu and Mitch Zhang from Longpack Manufacturing to delve into the ins and outs of how boardgames are made and why they're predominantly made in China.

China geht viral, wieder einmal: Nachdem 2025 die Labubus den Westen und das Internet erobert haben, ist jetzt ein neuer Trend entstanden, der auf folgende Formel gebracht werden kann: „You met me at a very chinese time in my life“.Westliche User, Influencer und Twitch-Streamer zeigen sich dabei, wie sie heißes Wasser trinken, chinesische Gerichte essen, Kaffeeketten aus China besuchen oder gleich in die Volksrepublik reisen, um von den pünktlichen Hochgeschwindigkeitszügen, der modernen Architektur, der E-Mobilität und der weit entwickelten Robotik zu schwärmen.Während der Westen schwächelt und das Antlitz des freundlichen US-Hegemons sehr grimmig ist, wird die chinesische Lebensart immer beliebter. Es ist deshalb wichtig, sich das Konzept von „Soft Power“ zu vergegenwärtigen, dem der Politikberater Joseph S. Nye 2004 ein eigenes Buch widmete. Was, wenn die Eroberung weniger durch Panzer als durch Plüschtiere und Popkultur vor sich geht?Mehr dazu von Ole Nymoen und Wolfgang M. Schmitt in der neue Folge von „Wohlstand für Alle“!Werbung: Ihr könnt das „Surplus“-Magazin jetzt vier Wochen lang für nur einen Euro testen und bekommt die KI-Ausgabe direkt nach Hause. https://www.surplusmagazin.de/wfa/Unsere Zusatzinhalte könnt ihr bei Apple Podcasts, Steady und Patreon hören. Vielen Dank!Apple Podcasts: https://podcasts.apple.com/de/podcast/wohlstand-f%C3%BCr-alle/id1476402723Patreon: https://www.patreon.com/oleundwolfgangSteady: https://steadyhq.com/de/oleundwolfgang/aboutLiteratur:Joseph S. Nye: Soft Power. The Means to Success in World Politics. Public Affairs.Die BBC über den Trend: https://www.bbc.com/news/articles/cz6eljqvyp1oWired-Artikel: https://www.wired.com/story/made-in-china-chinese-time-of-my-life/Veranstaltungen:Ole ist am 3. März in Magdeburg:https://www.magdeburg.de/B%C3%BCrger-Stadt/System/Veranstaltungskalender/-Warum-ich-niemals-f%C3%BCr-mein-Land-k%C3%A4mpfen-w%C3%BCrde-.php?ModID=11&FID=115.23034.1Wolfgang ist am 3. März in Erlangen: https://www.instagram.com/fsvphilfak/p/DVIlizsjVV_/Wolfgang ist am 10. März in Idar-Oberstein: https://penberlin.de/heimat_rp-mitwirkende/Wolfgang ist am 11. März in Duisburg: https://www.duisburger-akzente.de/de/programm_detail.php?eid=fbd0a0901377c932744f3afd87e07399&tid=7dcce52ec3b61931fd478d4b4b648565

Pj Chats with DoneDeal's Paddy Comyn on Chinese car brands making a major move into the Irish market. Hosted on Acast. See acast.com/privacy for more information.

Starkiller represents a significant escalation in phishing infrastructure. A blockchain lender breach affects nearly a million users. The Kimwolf botnet disrupts a peer-to-peer privacy network. Researchers identifiy vulnerabilities in widely used Visual Studio Code extensions. DEF CON bans three men named in the Epstein files. Texas sues TP-Link over supply chain security. Experts question the impact of cyber versus kinetic damage in Venezuela. African law enforcement arrest hundreds of suspected scammers. Tim Starks from CyberScoop explains CISA's upcoming town hall meetings over ICS reporting rules. Warsaw walls off Wi-Fi-wired wheels.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Today we are joined by Tim Starks from CyberScoop discussing “CISA to host industry feedback sessions on cyber incident reporting regulation.” Selected Reading Starkiller: New ‘Commercial-Grade' Phishing Kit Bypasses MFA (Infosecurity Magazine) Nearly 1 Million User Records Compromised in Figure Data Breach (SecurityWeek) Kimwolf Botnet Swamps Anonymity Network I2P (Krebs on Security) Flaws in Popular IDE Extensions Allow Data Exfiltration (Infosecurity Magazine) DEF CON bans three Epstein-linked men from future events (The Register) Texas sues TP-Link over Chinese hacking risks, user deception (Bleeping Computer) The Caracas operation suggests cyber was part of the plan – just not the whole operation (CyberScoop) Police arrests 651 suspects in African cybercrime crackdown (Bleeping Computer) Nigerian man gets eight years in prison for hacking tax firms (Bleeping Computer) Poland bans camera-packing cars made in China from military bases (The Register) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on Sinica, I speak with Kyle Chan, a fellow at the John L. Thornton China Center at Brookings, previously a postdoc at Princeton, and author of the outstanding High-Capacity Newsletter on Substack. Kyle has emerged as one of the sharpest and most empirically grounded voices on U.S.-China technology relations, and he holds the all-time record for the most namechecks on Sinica's “Paying it forward” segment. We use his recent Financial Times op-ed on “The Great Reversal” in global technology flows and his longer High-Capacity essay on re-coupling as jumping-off points for a wide-ranging conversation about where China now sits at the global technological frontier, why the dominant decoupling narrative misses powerful structural forces pulling the two economies back together, and what all of this means for innovation, choke points, and the global tech ecosystem.4:35 – How Kyle became Kyle Chan: from Chicago School economics to development, railways, and systems thinking 12:50 – The Great Reversal: China at the technological frontier, from megawatt EV charging to LFP batteries 17:59 – The electro-industrial tech stack and China's overlapping, mutually reinforcing tech ecosystems 22:40 – Industrial strategy and time horizons: patience, persistence, and the long arc of China's auto industry 33:45 – Re-coupling under pressure: Waymo and Zeekr, Unitree robots, and the structural forces binding the two economies 40:22 – The gravity model: can political distance overwhelm technological mass? 47:01 – What China still wants from the U.S.: Cursor, GitHub, talent, and the AI brain drain 51:52 – Weaponized interdependence and the danger of securitizing everything 57:30 – Firm-level adaptation: HeyGen, Manus, and the playbook for de-sinification 1:02:58 – The view from the middle: Gulf states, Southeast Asia, and India as geopolitical arbitrageurs 1:10:18 – Engineering resilience: what policymakers are getting wrong about the systems they're buildingPaying it forward: Katrina Northrop; Grace Shao and her AI Proem newsletterRecommendations:Kyle: Wired Magazine's Made in China newsletter (by Zeyi Yang and Louise Matsakis); The Wire China Kaiser: The Wall Dancers: Searching for Freedom and Connection on the Chinese Internet by Yi-Ling LiuSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Government yesterday published new guidance for schools in England on what to do when children question their gender. It says schools should not initiate steps towards social transitioning when pupils change their name or pronouns, and that toilets and changing rooms should be protected spaces, used according to biological sex. Branwen Jeffreys, the BBC's Education and Family Editor, joins Clare McDonnell to discuss this latest guidance.The one-child policy in China spanned a period of over 35 years. It led to large numbers of girls being abandoned by their birth mothers. And for many children, it's had a lasting impact on their lives. Eva Brookes has been reflecting on what that policy meant for her as she was adopted from China as a baby. Her new podcast series, Made in China, is out this week. In it she delves into her life in the UK and speaks to transracial children like herself, along with her own parents, and explores how it has shaped her own identity.North Korean leader Kim Jong Un has selected his daughter as his heir, South Korea's spy agency told lawmakers yesterday. Kim Ju Ae, who is believed to be 13, has in recent months been pictured beside her father in high-profile events including a visit to Beijing in September, her first known trip abroad. BBC Seoul correspondent Jake Kwon tells Clare about how surprising this selection is and what we know about her.Covent Garden is nowadays a centre for high-end designer shops, theatres and award-winning restaurants. However back in the 1700s it was a hotspot for taverns, coffee houses and prostitution. This is the colourful backdrop for the fourth novel from Louise Hare. Called The House of Fallen Sisters, it follows the story of Sukey, a mixed-race girl and an orphan, who has recently moved to London to live with her guardian - the guardian also happens to be a madam who runs a brothel and Sukey knows that once puberty hits, she too will join the women earning their keep. Louise tells Clare what drew her to this story. Presenter: Clare McDonnell Producer: Andrea Kidd

Born during the one-child rule, Eva Brookes knows almost nothing about her life before she was adopted by a British couple and raised in Essex. Hannah chats to Eva about her new BBC Sounds podcast Made in China, identity, Britishness and how it feels to discuss it, privately and publicly. * You can support us by becoming a Standard Issue patron here: Standard Issue Podcast | creating a magazine for ears, by women for women | Patreon Learn more about your ad choices. Visit megaphone.fm/adchoices

Italian Dumplings and Chinese Pizzas: Transcultural Food Mobilities (Fordham UP, 2025) by Dr. Gaoheng Zhang designs a novel analytical framework to approach transcultural food mobilities, a culinary phenomenon that has been with us for decades as a result of colonialism and globalization.Why is it surprising for some of us to read the pairing of “Chinese” with “pizzas” and “Italian” with “dumplings,” such as proposed in the book's title? After all, in some regions of the two countries, Italians eat frequently dumplings, and Chinese frequently make baked, steamed, or fried flatbread with toppings or fillings. Furthermore, when dumplings are made in Italy by Chinese migrants or Chinese Italians, or when pizzas are made in China by Italian migrants, Chinese Italians, or Chinese without apparent ties with Italy, are these culinary products Chinese, Italian, Chinese-Italian, or something else? Why do we need to care for such labeling dilemmas?This book shows how China-Italy food mobilities relayed in popular culture helped forge Chi­nese and Italians' socioeconomic identities in recent decades by fundamentally shaping contempo­rary Chinese and Italian consumer cultures. This book addresses China-Italy food cultures against the backdrops of two epoch-making socioeconomic processes. During the 1980s, Chinese cuisine became the first non-European food widely available in Italy, thanks to the widespread presence of Chinese eateries. Only American fast food, which established itself in Italy around the same time, enjoyed comparable popularity as a destination for Italian culinary tourism. Meanwhile, in the early 1990s, together with American hamburgers and fried chicken, the American food chain Pizza Hut's pizzas and spaghetti were the first non-Asian foods that post-Mao Chinese customers recognized as “Western.” The book proposes a critical framework that analyzes transcultural food mobilities by seriously assessing the confluence of diverse mobilities and their impact on food cultures. Ulti­mately, the study shows that a sophisticated interpretation of transcultural food mobilities can help address alterity and build understanding in a world of increasing political and cultural polarization. This interview was conducted by Dr. Miranda Melcher whose book focuses on post-conflict military integration, understanding treaty negotiation and implementation in civil war contexts, with qualitative analysis of the Angolan and Mozambican civil wars. You can find Miranda's interviews on New Books with Miranda Melcher, wherever you get your podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

World leaders are flocking to Beijing. In the first weeks of 2026, Canada's Mark Carney, the UK's Sir Keir Starmer and South Korea's Lee Jae-myung have all made high-profile visits - an unmistakable signal of global power recalibrating.China's dominance in clean energy manufacturing is already well established: from solar panels and batteries to wind turbines. The question now is whether this transition remains merely made in China, or whether it is increasingly being shaped and led from Beijing.Christiana Figueres, Tom Rivett-Carnac and Paul Dickinson consider what this shift may mean for the future of climate leadership - and for the institutions, alliances and norms that have shaped global climate cooperation for decades. They're joined by scholar of China's political economy and climate governance Yixian Sun, who has recently advised the UK government on their engagement with China. He unpacks the country's own vision of leadership, its evolving role in the Global South, and the risks and opportunities of an increasingly multipolar climate order.As the world recalibrates around China's growing role, how does Beijing see itself? And what are other governments actually seeking as they turn towards it? We spoke to the man advising the UK government ahead of Keir Starmer's arrival in Beijing.

China is winning the culture war: From "galvanized square steel" to drinking hot water, why is the entire internet suddenly looking more Chinese?Support my independent journalism:

In one of the worst “Made in China” product disasters in recent memory, 10 people in the United States have recently either died or been seriously wounded when the airbag in their car went off and blasted their face, neck, and chest with metal shrapnel.Instead of creating a pillow to cushion the impact, these made-in-China airbags acted like grenades—so far killing eight drivers in what would've otherwise been survivable crashes—and seriously injuring two others.Let's go through what we know about these airbags, how they're getting into cars, why they're killing people, as well as how you can check your own car to see whether you're safe.

Mark Carney was in China for the past few days and leaves with a pocketful of deals. Sounds good but how good is it? It's a busy Good Talk with more on the agenda, from the resignation of Quebec's premier to what exactly is Canada's position on Greenland? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

China is in trouble. Their agenda has been thwarted by Trump. And Chinese and Russian disinformation campaigns no longer work as they have in the past. How will they be able to compete long-term?Remember my many discussions about Trump playing the long-game? With a recent declaration, Trump shot over the Chinese bow…Trump is genuinely not afraid of ChinaChina didn't kick down the door of the American economy. It slipped in through the souvenir shop.No tanks. No missiles. Just cheap plastic, novelty mugs, and “Made in China” stamped so small you needed a jeweler's loupe and a prayer to spot it. While America argued about pronouns and carbon footprints, China was quietly selling us our own nostalgia back at a discount. We called it globalization. They called it Tuesday.That's the part most people miss when they talk about trade. They focus on factories the size of cities, container ships stacked like Lego sets, and steel tariffs that make economists sweat through their khakis. But President Donald Trump understands something that the Ivy League trade priests never did: empires don't collapse from a single cannon blast. They bleed out from a million paper cuts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Burnie and Ashley discuss the great Chinese catch up, EUV chips, research milestones, and all the Marvel teasers.